DV Doppler study
Ductus Venosus (DV) Fetal Doppler & normal value
Normal Value
Ductus Venosus (DV) Doppler
Ductus Venosus (DV) Doppler assesses blood flow in the ductus venosus, a small venous shunt unique to fetal circulation that permits umbilical venous blood to bypass the liver and enter directly into the inferior vena cava. The ductus venosus plays a critical role in fetal hemodynamics, particularly during heart rate accelerations and fetal breathing. Doppler waveforms of the ductus venosus reflect hepatic vascular resistance and right heart function. In normal pregnancies, the DV waveform shows continuous antegrade flow during systole (S), diastole (D), and atrial contraction (A-wave). In fetal compromise, particularly severe intrauterine growth restriction (IUGR) with placental insufficiency or cardiac dysfunction, the DV waveform deteriorates progressively, eventually showing reversed or absent flow during atrial contraction—a sign of severe fetal compromise and increased risk of perinatal mortality.
S/D ratio → S/D ratio (Systolic/Diastolic ratio) in Ductus Venosus is the ratio of peak systolic velocity (S) to peak diastolic velocity (D) in the ductus venosus waveform. It reflects hepatic vascular resistance and fetal hemodynamic status.
Formula:
DV S/D ratio = Peak Systolic Velocity (S) ÷ Peak Diastolic Velocity (D)
What it measures:
The ductus venosus carries oxygenated, nutrient-rich umbilical venous blood. Under normal conditions, the DV displays a characteristic triphasic waveform with flow in systole (S), diastole (D), and atrial contraction (A-wave). The S/D ratio reflects the change in hepatic vascular resistance and cardiac performance across the cardiac cycle. In normal fetuses, systolic flow is highest, diastolic flow remains positive, and the S/D ratio is relatively stable across gestation. In fetal compromise—particularly severe IUGR with placental insufficiency or right heart dysfunction—vascular resistance rises, diastolic flow decreases, and the S/D ratio increases. In severe cases, diastolic and/or atrial flows become reversed (negative), indicating critical hemodynamic derangement and imminent fetal decompensation.
• 20 weeks: ~3.0–3.5
• 28 weeks: ~2.8–3.2
• 34 weeks: ~2.5–3.0
• 40 weeks: ~2.3–2.8
Measuring technique for DV S/D:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava.
4. Maintain angle of insonation close to 0° for accurate velocity measurement.
5. Measure during fetal rest (no breathing / movement), capture at least 3 uniform waveforms.
6. On each waveform, identify three peaks: S (systolic peak), D (diastolic peak), and A (atrial contraction peak).
7. Most machines auto-calculate S/D, RI, and PI; record the mean of 3 waveforms for reporting.
8. Note the presence, direction, and magnitude of A-wave flow; reversed A-wave is a critical finding.
Normal S/D Ratio Reference Values for Ductus Venosus by Gestational Age
Abnormal patterns:
• S/D > 95th centile for GA → Elevated hepatic vascular resistance; reduced diastolic flow. Indicates placental insufficiency, IUGR, or cardiac dysfunction.
• S/D progressively increasing across serial scans → Worsening hepatic resistance and fetal compromise; risk of decompensation.
• Absent or severely reduced diastolic flow in DV → Critical hemodynamic deterioration; imminent fetal decompensation risk.
• Reversed A-wave (atrial contraction showing reversed flow) → Sign of severe fetal compromise, right heart dysfunction, or tricuspid regurgitation. Associated with high perinatal mortality risk; urgent delivery consideration if ≥34 weeks.
• Reversed S-wave (rarely occurs) → Extreme hemodynamic derangement; immediate delivery consideration.
Prognostic value of DV Doppler abnormalities:
The ductus venosus Doppler is among the most sensitive markers of fetal hemodynamic compromise. Abnormal DV waveforms, particularly reversed A-waves, carry a high predictive value for adverse perinatal outcome in IUGR fetuses. DV assessment is especially valuable in early-onset IUGR (before 32 weeks), where it guides delivery timing and helps differentiate constitutionally small fetuses from those with true placental insufficiency.
Clinical Decision Thresholds (DV S/D and PI)
Key points to remember:
• DV S/D ratio and PI are slowly declining with advancing gestation, but changes are subtle. Focus on trend and absolute deviation from centiles, not minor variations.
• The A-wave (atrial contraction wave) is the most clinically important component of the DV waveform; always assess its presence and direction.
• Reversed or absent A-wave is a critical finding indicating severe compromise and elevated perinatal mortality risk—demands urgent clinical decision-making.
• DV Doppler is particularly valuable in early-onset IUGR (before 32 weeks) where it helps guide delivery timing and predicts outcome better than umbilical artery Doppler alone.
• Always interpret DV findings in context of concurrent UA and MCA Doppler (Doppler index concept) and fetal biometry.
• PI is preferred over S/D ratio for DV assessment in modern practice, as it is more standardized and angle-independent.
• Measure on the proximal ductus venosus near entry into the IVC; sampling from the mid or distal DV may yield spurious results.
• Ensure angle correction is applied (maintain 0° angle) or use angle-independent indices (PI, RI).
• Absent or reversed DV flow patterns warrant delivery planning within 24–48 hours (or immediately if <34 weeks with other signs of compromise).
• Combine DV with umbilical artery and MCA assessment to construct the complete hemodynamic picture: elevated UA + elevated DV + reduced MCA = severe IUGR with decompensation.
RI (Resistance Index) → RI (Resistance Index) in Ductus Venosus is a normalized, angle-independent Doppler index that quantifies vascular resistance by measuring the relationship between peak systolic velocity (S), end-diastolic velocity (D), and mean velocity (MV). It reflects hepatic vascular resistance and fetal hemodynamic status more reliably than S/D ratio alone.
Formula:
DV RI = (Peak Systolic Velocity − End-Diastolic Velocity) ÷ Peak Systolic Velocity
DV RI = (S − D) ÷ S
Advantages of RI over S/D ratio:
The Resistance Index offers several clinical advantages:
• Angle-independent: RI is mathematically normalized and remains valid across angle variations (0° to 60°), whereas S/D is angle-dependent.
• Normalizes resistance: RI expresses resistance as a proportion of systolic velocity, providing a standardized measure comparable across different vessels and time points.
• Remains valid at extreme resistances: Unlike S/D, which becomes mathematically invalid or unreliable when diastolic flow approaches zero or reverses, RI handles absent/reversed diastolic and atrial flows mathematically (RI can reach 1.0 at zero diastolic flow, and technically exceed 1.0 with reversed flow).
• Better reproducibility: RI shows improved inter-observer and intra-observer agreement, making it preferred for serial monitoring and quality assurance.
• Standardized centiles: Most modern Doppler reference databases provide age-specific RI centiles; RI-based decisions align with current guidelines and research.
What DV RI measures:
The ductus venosus carries oxygenated, nutrient-rich umbilical venous blood. Under normal conditions, the DV displays a characteristic triphasic waveform with flow in systole (S), diastole (D), and atrial contraction (A-wave). The RI reflects the change in hepatic vascular resistance and cardiac performance across the cardiac cycle. In normal fetuses, systolic flow is highest, diastolic and atrial flows remain positive, and the RI is relatively stable across gestation, ranging from approximately 0.50–0.70. In fetal compromise—particularly severe IUGR with placental insufficiency or right heart dysfunction—vascular resistance rises, diastolic flow decreases, RI increases, and the waveform flattens. In severe cases, diastolic and/or atrial flows become reversed (negative), RI approaches or exceeds 1.0, indicating critical hemodynamic derangement and imminent fetal decompensation.
• 16–20 weeks: ~0.60–0.75 (normal baseline)
• 24–28 weeks: ~0.55–0.70 (stable mid-gestation)
• 32–36 weeks: ~0.50–0.65 (late trimester maturation)
• 38–42 weeks: ~0.48–0.62 (term values)
Measuring technique for DV RI:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava, avoiding the junction to prevent artifacts.
4. Maintain angle of insonation as close to 0° as possible (though RI is more forgiving of angle error than S/D).
5. Measure during fetal rest (no breathing / movement); avoid fetal breathing movements which distort the waveform.
6. Capture at least 3–4 uniform, representative waveforms during a stable, quiescent period.
7. On each waveform, identify: S (systolic peak), D (end-diastolic point), and calculate mean velocity (MV) from the velocity envelope.
8. Most ultrasound machines automatically calculate RI; record the mean RI from 3–4 waveforms for reporting.
9. Always note the presence, direction, and appearance of the A-wave (atrial contraction wave); reversed A-wave is a critical finding even if RI is mildly abnormal.
10. Document sample volume position, angle, and technical quality to ensure reproducibility for serial measurements.
Normal RI Reference Values for Ductus Venosus by Gestational Age
Abnormal RI patterns and clinical significance:
• DV RI > 95th centile for GA → Elevated hepatic vascular resistance; reduced diastolic flow. Indicates placental insufficiency, IUGR, or early cardiac dysfunction. Action: Confirm IUGR status; serial Doppler monitoring every 3–7 days.
• DV RI > 0.70 at term (or > 95th centile) → Significant resistance elevation; warrants investigation for IUGR, growth restriction, or cardiac anomaly.
• DV RI progressively increasing across serial scans → Worsening hepatic resistance and deteriorating fetal hemodynamics; risk of acute decompensation. Action: Consider delivery if ≥34 weeks; escalate surveillance.
• RI approaching or reaching 1.0 → Severely reduced or absent diastolic flow; critical hemodynamic derangement.
• RI > 1.0 or calculation impossible → Diastolic flow is reversed (negative), indicating reversed flow during diastole or atrial contraction. This reflects critical right heart dysfunction or severe tricuspid regurgitation. Action: URGENT delivery consideration if ≥34 weeks; immediate clinical assessment if <34 weeks.
• Reversed or absent A-wave with RI > 95th centile → Combination finding indicating severe fetal compromise with right atrial pressure elevation or tricuspid valve insufficiency. Action: URGENT evaluation; delivery planning within 24–48 hours if ≥32 weeks.
Prognostic value of DV RI abnormalities:
The ductus venosus RI is among the most sensitive and specific markers of fetal hemodynamic compromise. Abnormal DV RI, particularly when combined with reversed A-waves or reversed diastolic flow, carries a high predictive value for adverse perinatal outcome in IUGR fetuses. DV assessment is especially valuable in early-onset IUGR (before 32 weeks), where it guides delivery timing, predicts outcome better than umbilical artery Doppler alone, and helps differentiate constitutionally small fetuses from those with true placental insufficiency and hemodynamic compromise.
Clinical Decision Thresholds (DV RI)
Key points to remember:
• DV RI is angle-independent and normalized—superior to S/D ratio for serial monitoring and quality assurance.
• DV RI slowly declines with advancing gestation, but changes are subtle; focus on trend and absolute deviation from age-specific centiles, not minor variations.
�� The A-wave (atrial contraction wave) is clinically crucial; always assess its presence, direction, and amplitude.
• Reversed or absent A-wave is a critical, time-sensitive finding indicating severe compromise and elevated perinatal mortality—demands urgent clinical decision-making even if RI is borderline.
• RI ≥ 1.0 or reversed diastolic flow is a medical emergency; coordinate immediate obstetric and neonatal planning.
• DV RI is particularly valuable in early-onset IUGR (before 32 weeks) where it predicts outcome better than umbilical artery Doppler alone.
• Always interpret DV findings in context of concurrent UA (umbilical artery) and MCA (middle cerebral artery) Doppler and fetal growth parameters.
• Doppler index concept: Elevated UA RI + elevated DV RI + reduced MCA RI = severe IUGR with hemodynamic decompensation.
• Measure on the proximal ductus venosus near entry into the IVC; sampling from mid or distal DV may yield spurious results.
• Ensure adequate angle correction is applied (maintain 0° angle when possible), although RI is more forgiving of angle variations than S/D.
• Serial DV monitoring is essential; a single abnormal value requires confirmation and trend assessment before major clinical decisions.
• DV RI deterioration (progressive increase) across repeated scans is often more clinically significant than a single abnormal value.
• In borderline cases (RI at 90th–95th centile), combine DV RI assessment with CTG, growth parameters, and other vessel Doppler indices before deciding on intervention.
PI (Pulsatility Index) → PI (Pulsatility Index) in Ductus Venosus is a normalized, angle-independent Doppler index that quantifies vascular resistance and blood flow pulsatility by measuring the relationship between peak systolic velocity (S), end-diastolic velocity (D), and mean velocity (MV) across the entire cardiac cycle. It reflects hepatic vascular resistance, venous compliance, and right heart function more comprehensively than S/D ratio or RI alone.
Formula:
DV PI = (Peak Systolic Velocity − End-Diastolic Velocity) ÷ Mean Velocity
DV PI = (S − D) ÷ MV
Advantages of PI over S/D ratio and RI:
The Pulsatility Index offers multiple clinical advantages and is now the preferred primary Doppler index in most modern centres:
• Angle-independent: PI is mathematically normalized and remains valid across angle variations (0° to 60°), accounting for the entire flow profile.
• Accounts for mean velocity: Unlike S/D and RI which use only peak and diastolic components, PI incorporates mean velocity from the entire velocity envelope, providing a more complete hemodynamic assessment.
• Normalizes pulsatility: PI expresses the difference between systolic and diastolic components as a proportion of mean velocity, providing a standardized measure of vascular resistance, compliance, and afterload.
• Remains valid at extreme resistances: PI is mathematically sound even when diastolic flow approaches zero or reverses (though interpretation requires concurrent A-wave assessment).
• Superior prognostic value: PI shows stronger correlation with adverse perinatal outcomes in IUGR compared to S/D ratio and superior reproducibility compared to RI.
• Better reproducibility: PI demonstrates excellent inter-observer and intra-observer agreement, making it the gold standard for serial monitoring.
• Standardized centiles globally: Most major Doppler reference databases (GSPOD, KANET, etc.) provide age-specific PI centiles; PI-based decisions align with current international guidelines and research.
• Single comprehensive index: PI captures both resistance and compliance changes, reducing need for multiple indices in clinical practice.
What DV PI measures:
The ductus venosus carries oxygenated, nutrient-rich umbilical venous blood under low-resistance, high-compliance conditions. Under normal conditions, the DV displays a characteristic triphasic waveform with flow in systole (S), diastole (D), and atrial contraction (A-wave), with relatively small pulsatile variations proportional to cardiac afterload. The PI reflects the combination of hepatic vascular resistance and the pulsatile energy transmitted from the right heart through the venous system. In normal fetuses, PI is relatively stable across gestation (approximately 0.40–0.85), reflecting consistent venous compliance and afterload. In fetal compromise—particularly severe IUGR with placental insufficiency or right heart dysfunction—vascular resistance and afterload rise, diastolic and atrial flows decrease, the waveform becomes more pulsatile, and PI increases. In severe cases, diastolic and/or atrial flows become reversed (negative), PI continues to rise, indicating critical hemodynamic derangement and imminent fetal decompensation.
• 16–20 weeks: ~0.60–0.85 (normal baseline)
• 24–28 weeks: ~0.50–0.75 (stable mid-gestation)
• 32–36 weeks: ~0.42–0.68 (late trimester maturation)
• 38–42 weeks: ~0.38–0.65 (term values)
Measuring technique for DV PI:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava, avoiding the junction to prevent artifacts.
4. Maintain angle of insonation as close to 0° as possible (though PI is more forgiving of angle error than S/D).
5. Measure during fetal rest (no breathing / movement); avoid fetal breathing movements which distort the waveform and increase pulsatility variability.
6. Capture at least 3–4 uniform, representative waveforms during a stable, quiescent period. Avoid measuring during fetal hiccoughs or acelerations.
7. On each waveform, the ultrasound machine traces the velocity envelope (outer border of the Doppler signal) and automatically calculates S (systolic peak), D (end-diastolic point), and MV (mean velocity).
8. Most modern ultrasound machines automatically calculate and display PI; record the mean PI from 3–4 representative waveforms for reporting.
9. Always note the presence, direction, and appearance of the A-wave (atrial contraction wave); reversed or diminished A-wave is a critical finding and must be documented separately.
10. Document sample volume position, angle, technical quality, fetal state (quiescent vs. active), and any technical limitations to ensure reproducibility for serial measurements.
Normal PI Reference Values for Ductus Venosus by Gestational Age
Abnormal PI patterns and clinical significance:
• DV PI > 95th centile for GA → Elevated hepatic vascular resistance and increased pulsatility; reduced diastolic flow. Indicates placental insufficiency, IUGR, or early cardiac dysfunction. Action: Confirm IUGR status with biometry; assess UA and MCA Doppler; serial DV PI every 3–7 days.
• DV PI > 0.70 at term (or > 95th centile) → Significant resistance elevation and waveform distortion; warrants investigation for IUGR, growth restriction, or cardiac/venous anomaly.
• DV PI progressively increasing across serial scans → Worsening hepatic resistance, increasing afterload, and deteriorating fetal hemodynamics; high risk of acute decompensation. Action: Consider delivery if ≥34 weeks; escalate surveillance to twice-weekly CTG; assess umbilical artery Doppler.
• DV PI markedly elevated (e.g., > 1.0 at term) → Severely elevated pulsatility; critically reduced diastolic flow; hemodynamic derangement. Action: URGENT assessment; consider delivery if ≥32 weeks; evaluate cardiac function.
• DV PI with reversed A-wave (abnormal atrial flow) → Elevated PI combined with reversed/absent atrial contraction flow is a critical marker of severe hemodynamic failure, indicating right atrial pressure elevation or tricuspid insufficiency. Action: URGENT delivery consideration if ≥32 weeks; immediate clinical assessment.
• Rapidly rising DV PI (steep trend) → Progressive waveform deterioration indicating acute hemodynamic decompensation risk. Action: Daily CTG; urgent delivery consideration if ≥30 weeks; transfer to tertiary centre if <32 weeks.
Prognostic value of DV PI abnormalities:
The ductus venosus PI is among the most sensitive and specific markers of fetal hemodynamic compromise and is now considered the gold standard venous Doppler index in modern perinatology. Abnormal DV PI, particularly when combined with reversed A-waves or progressive elevation, carries a high predictive value for adverse perinatal outcome in IUGR fetuses. DV PI assessment is especially valuable in early-onset IUGR (before 32 weeks), where it guides delivery timing with greater precision than umbilical artery Doppler alone, predicts intrauterine fetal death (IFOD) and neonatal death better than arterial indices, and helps differentiate constitutionally small fetuses from those with true placental insufficiency and hemodynamic decompensation. Reversed DV A-wave is an independent marker of poor perinatal outcome and warrants delivery planning within 24–48 hours at ≥32 weeks.
Clinical Decision Thresholds (DV PI)
DV PI Combined with Other Doppler Indices (Doppler Index Concept):
Modern IUGR surveillance uses integrated Doppler assessment combining multiple vessel indices:
• Elevated UA PI + Elevated DV PI + Reduced MCA PI = Severe IUGR with hemodynamic redistribution; high-risk group requiring close monitoring and delivery planning.
• Normal UA PI + Elevated DV PI = Right heart dysfunction or primary venous disease (rare); requires cardiac evaluation.
• Elevated UA PI + Normal DV PI + Normal MCA PI = Mild placental insufficiency; lower imminent risk; continue standard surveillance.
• Elevated UA PI + Normal DV PI + Reduced MCA PI = Brain-sparing effect without venous involvement; intermediate risk.
Key points to remember:
• DV PI is angle-independent, normalized, and comprehensive—now the preferred primary DV index in modern centres; use in preference to S/D ratio.
• DV PI incorporates mean velocity from the entire cardiac cycle, providing superior hemodynamic assessment compared to S/D or RI alone.
• DV PI slowly declines with advancing gestation; focus on trend and centile deviation rather than absolute values.
• The A-wave (atrial contraction wave) is clinically crucial; always assess its presence, direction, amplitude, and trend. Reversed A-wave is a critical finding even if PI is borderline abnormal.
• Reversed or absent A-wave with abnormal PI is a time-sensitive, urgent marker of severe hemodynamic failure requiring delivery planning.
• DV PI is particularly valuable in early-onset IUGR (before 32 weeks) where it predicts adverse outcome better than arterial indices and guides delivery decisions.
• Progressive DV PI elevation (steep trend across serial scans) is often more clinically significant than a single abnormal value; implies decompensation risk.
• Always interpret DV PI in context of concurrent UA PI (umbilical artery) and MCA PI (middle cerebral artery) Doppler and fetal growth parameters.
• Doppler index concept: Integrated assessment of UA, DV, and MCA indices provides superior prediction of adverse outcome compared to single-vessel assessment.
• Measure on the proximal ductus venosus near entry into the IVC; avoid mid or distal DV sampling which may yield spurious results.
• Fetal state matters: Measure during fetal quiescence; avoid measurement during breathing movements or hiccoughs which artificially increase PI.
• Serial DV monitoring is essential; establish a baseline and trend; a single abnormal PI requires confirmation and context before major decisions.
• In borderline cases (PI at 90th–95th centile), combine DV PI assessment with CTG, growth velocity, UA Doppler, and other parameters before deciding on intervention.
• DV PI combined with abnormal venous waveform morphology (flattened diastole, absent A-wave) indicates high-risk hemodynamic state warranting urgent action.
PSV (Peak Systolic Velocity) → PSV (Peak Systolic Velocity) in Ductus Venosus is the maximum blood flow velocity recorded in the ductus venosus waveform during the systolic (ventricular contraction) phase of the cardiac cycle. It is an absolute velocity measurement expressed in cm/s, representing the peak instantaneous flow speed during right ventricular systole.
Definition and measurement:
DV PSV = The highest point on the Doppler waveform during systole, measured in cm/s
What DV PSV measures:
PSV is a direct measure of peak flow velocity, which is influenced by:
• Right heart contractility: PSV increases with stronger ventricular contraction and cardiac output.
• Hepatic afterload: PSV decreases when hepatic vascular resistance rises (e.g., in liver congestion or cirrhosis—rare in fetuses).
• Circulating blood volume: PSV may decrease with fetal anemia or hypovolemia, and increase with polycythemia.
• Angle of insonation: PSV is angle-dependent; measurements at angle >30° become unreliable. Always apply angle correction or maintain angle <15°.
• Transducer position and technique: Slight changes in sample volume position along the DV can alter PSV; standardized measurement technique is essential.
Clinical significance of DV PSV:
Unlike normalized indices (PI, RI) which reflect resistance independent of flow, PSV provides information about absolute flow speed and cardiac output. PSV alone has limited independent prognostic value in IUGR assessment because it can vary widely based on multiple factors unrelated to hemodynamic compromise (angle, technique, cardiac output state). However, PSV becomes clinically significant in specific contexts:
• Markedly reduced PSV + abnormal PI/RI → Indicates severe hemodynamic deterioration with reduced cardiac output.
• Progressive decline in PSV across serial scans → Suggests worsening right heart function or cardiac output.
• Severely reduced PSV + reversed A-wave → Critical hemodynamic failure with reduced systolic function.
• Elevated PSV + normal/low PI → May indicate compensatory increased cardiac output (e.g., in anemia).
Measuring technique for DV PSV:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava.
4. Angle correction is critical for PSV measurement: Align the Doppler beam as parallel as possible to the ductus venosus flow direction; maintain angle of insonation <15° for optimal accuracy; apply angle correction on the ultrasound machine for angles 0°–30°.
5. Measure during fetal rest (no breathing / movement); avoid fetal breathing movements which increase PSV variability.
6. Capture 3–4 uniform, representative waveforms during a stable period.
7. On each waveform, identify the highest point during the systolic phase (the peak of the first, largest envelope deflection).
8. Most modern ultrasound machines automatically measure PSV; record the mean PSV from 3–4 waveforms for reporting (express in cm/s).
9. Document the angle of insonation, angle correction applied, sample volume position, and technical quality for reproducibility.
10. Always measure PSV in context of concurrent end-diastolic velocity (EDV), PI, RI, and A-wave assessment for complete hemodynamic evaluation.
Normal PSV Reference Values for Ductus Venosus by Gestational Age
Abnormal DV PSV patterns and clinical significance:
• PSV < 5th centile for GA (e.g., < 35 cm/s at 28 weeks) → Markedly reduced systolic flow velocity. If concurrent normal PI/RI, may indicate anemia, hypovolemia, or reduced cardiac output without resistance change. If concurrent elevated PI/RI, indicates severe hemodynamic compromise with reduced systolic function. Action: Assess hemoglobin/hematocrit; investigate cardiac function; serial monitoring.
• PSV progressively declining across serial scans → Worsening right ventricular systolic function or cardiac output deterioration. Action: Escalate surveillance; evaluate cardiac function; consider delivery if ≥32 weeks with other abnormalities.
• Severely reduced PSV (< 25 cm/s) + elevated PI + reversed A-wave → Critical triad indicating severe systolic dysfunction, hemodynamic failure, and imminent decompensation. Action: URGENT delivery if ≥32 weeks; immediate clinical assessment if <32 weeks.
• Elevated PSV (> 95th centile) + normal PI/RI → Increased flow velocity, may indicate compensatory increased cardiac output (e.g., anemia, polycythemia) without resistance elevation. Action: Assess fetal hemoglobin; investigate for anemia or other high-output states.
• Normal PSV + abnormal PI/RI + reversed A-wave → Resistance elevation and right heart dysfunction despite preserved systolic velocity; indicates venous or cardiac dysfunction without acute systolic failure. Action: Investigate cardiac function; urgent delivery consideration if ≥32 weeks.
Limitations of PSV as a standalone parameter:
PSV is angle-dependent, technique-dependent, and influenced by multiple non-hemodynamic factors (heart rate, cardiac contractility, blood volume, anemia, etc.). It provides limited independent prognostic value in IUGR and should never be used as a sole criterion for clinical decisions. PSV is most useful when:
• Combined with normalized indices (PI, RI) to provide complete hemodynamic assessment.
• Tracked serially to assess trend in cardiac output across time.
• Interpreted in context of A-wave status, diastolic flow, and other vessel Doppler.
• Used to investigate specific clinical questions (suspected anemia, cardiac dysfunction, high-output states).
Clinical Decision Framework (DV PSV in Context)
DV PSV Combined with Other Parameters:
For comprehensive fetal hemodynamic assessment, always integrate DV PSV with:
• Diastolic and mean velocities: Calculate PI and RI for normalized resistance assessment.
• A-wave assessment: Reversed/absent A-wave is a critical finding independent of PSV.
• Umbilical artery (UA) Doppler: Elevated UA PI/RI indicates placental insufficiency; combined with abnormal DV suggests IUGR with hemodynamic redistribution.
• Middle cerebral artery (MCA) Doppler: Reduced MCA PI indicates brain-sparing effect.
• Fetal growth parameters: Biometry (AC, EFW) confirms IUGR status.
• Fetal heart rate and heart rate variability: Bradycardia or reduced variability suggests fetal distress.
• Amniotic fluid volume: Oligohydramnios indicates more severe placental insufficiency.
Key points to remember:
• DV PSV is an absolute velocity measurement, not a resistance index; it reflects multiple factors (cardiac output, heart rate, blood volume, anemia, angle).
• PSV alone has limited prognostic value in IUGR; always interpret in context of normalized indices (PI, RI), A-wave status, and clinical parameters.
• PSV progressively increases with advancing gestation (42 cm/s at 16 weeks to 80 cm/s at 42 weeks) reflecting rising fetal cardiac output.
• Angle correction is essential for PSV accuracy; maintain insonation angle <15° or apply proper angle correction for angles up to 30°.
• Markedly reduced PSV + elevated PI/RI indicates severe systolic dysfunction and hemodynamic failure; urgent action warranted.
• Normal PSV + abnormal PI/RI indicates resistance/compliance abnormality without acute systolic dysfunction; still warrants investigation and monitoring.
• Elevated PSV + normal PI/RI + normal A-wave may indicate compensatory increased cardiac output (e.g., anemia); assess hemoglobin.
• Declining PSV trend across serial scans is more clinically significant than a single abnormal value; suggests progressive cardiac deterioration.
• PSV should always be measured on the proximal ductus venosus near entry into the IVC for standardization; mid or distal DV measurement yields different values.
• Fetal state matters: Measure during fetal quiescence; avoid measurement during breathing movements or hiccoughs which artificially alter PSV.
• Never use PSV alone for delivery decisions; integrate with PI/RI, A-wave, CTG, growth, and clinical context.
• Reversed A-wave is critical regardless of PSV—reversed A-wave with normal PSV still warrants urgent intervention if ≥32 weeks.
• DV PSV is most useful as part of comprehensive Doppler index assessment (UA + DV + MCA) for complete hemodynamic picture.
EDV (End-Diastolic Velocity) → EDV (End-Diastolic Velocity) in Ductus Venosus is the blood flow velocity recorded at the end of diastole (immediately before atrial contraction) in the ductus venosus waveform. It is an absolute velocity measurement expressed in cm/s, representing the lowest flow point during ventricular diastole and reflecting diastolic afterload and hepatic vascular resistance.
Definition and measurement:
DV EDV = The flow velocity at the end of the diastolic phase (just before the A-wave), measured in cm/s
What DV EDV measures:
EDV is a direct measure of diastolic flow velocity, which is predominantly determined by:
• Hepatic vascular resistance: EDV decreases as hepatic resistance rises (the primary driver in fetal IUGR). As placental insufficiency develops, hepatic vascular resistance increases, diastolic flow drops progressively.
• Right atrial pressure: Elevated right atrial pressure (from right heart dysfunction, tricuspid regurgitation, or venous congestion) reduces diastolic flow and can cause reversed diastolic flow.
• Venous compliance: Reduced compliance increases afterload and lowers diastolic velocity.
• Heart rate: Tachycardia shortens diastole and may artificially lower EDV measurements; bradycardia lengthens diastole.
• Angle of insonation: EDV is angle-dependent; measurements at angle >30° become unreliable.
• Fetal state: Breathing movements increase pulsatility and EDV variability; measurement during quiescence is essential.
Clinical significance of DV EDV:
EDV is clinically more significant than PSV in IUGR assessment because diastolic flow directly reflects vascular afterload and resistance:
• Reduced EDV (< 5th centile for GA) → Elevated hepatic vascular resistance; indicates placental insufficiency and IUGR.
• Absent EDV (near-zero diastolic flow) → Severe resistance elevation; critical hemodynamic deterioration; imminent decompensation.
• Reversed EDV (negative diastolic flow) → Flow reversal during diastole; critical right atrial pressure elevation; severe right heart dysfunction or tricuspid regurgitation; medical emergency.
• Progressive decline in EDV → Worsening resistance; high risk of acute decompensation.
• Absent or reversed EDV + reversed A-wave → Catastrophic hemodynamic failure; imminent fetal demise risk; URGENT delivery.
Measuring technique for DV EDV:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava.
4. Angle correction is critical for EDV measurement: Align the Doppler beam as parallel as possible to the ductus venosus flow direction; maintain angle of insonation <15° for optimal accuracy; apply angle correction on the ultrasound machine for angles 0°–30°.
5. Measure during fetal rest (no breathing / movement); avoid fetal breathing movements which distort EDV and increase pulsatility.
6. Capture 3–4 uniform, representative waveforms during a stable, quiescent period.
7. On each waveform, identify the lowest point during the diastolic phase, just before the A-wave (atrial contraction) begins. This is typically the trough of the waveform between the main systolic peak and the smaller A-wave peak.
8. Most modern ultrasound machines automatically measure EDV; record the mean EDV from 3–4 waveforms for reporting (express in cm/s).
9. Note the presence and direction of diastolic flow: Positive EDV indicates antegrade (toward heart) flow; absent EDV indicates near-zero diastolic flow; negative EDV indicates reversed (retrograde) diastolic flow.
10. Always measure EDV in context of concurrent PSV, PI, RI, and A-wave assessment for complete hemodynamic evaluation.
11. Document angle of insonation, angle correction applied, diastolic flow direction, sample volume position, and technical quality for reproducibility.
Normal EDV Reference Values for Ductus Venosus by Gestational Age
Abnormal DV EDV patterns and clinical significance:
• EDV < 5th centile for GA (e.g., < 10 cm/s at 28 weeks) → Markedly reduced diastolic flow velocity. Indicates elevated hepatic vascular resistance from placental insufficiency, IUGR, or right heart dysfunction. Action: Confirm IUGR with biometry; assess UA and MCA Doppler; serial monitoring every 3–7 days; consider delivery if ≥34 weeks with growth restriction.
• EDV approaching zero (near-absent diastolic flow) → Severely elevated hepatic vascular resistance; critical hemodynamic deterioration. Action: Daily CTG if ≥28 weeks; assess PI/RI for complete picture; urgent delivery consideration if ≥32 weeks.
• Absent EDV (zero diastolic flow) → No flow during diastole; critical resistance elevation; precursor to reversed diastolic flow. Action: URGENT evaluation; escalate to twice-daily CTG; deliver if ≥32 weeks; tertiary referral if <32 weeks.
• Reversed EDV (negative diastolic flow) → Retrograde flow during diastole; reversed velocity toward the umbilical vein; indicates severe right atrial pressure elevation exceeding ductus venosus pressure. Sign of severe right heart dysfunction, tricuspid regurgitation, or hepatic congestion. Action: MEDICAL EMERGENCY; URGENT/EMERGENT delivery if ≥32 weeks; dual obstetric-neonatal team mobilization; neonatal resuscitation standby.
• EDV progressively declining across serial scans → Worsening hepatic resistance and deteriorating fetal hemodynamics; high risk of acute decompensation. Action: Accelerate surveillance to daily CTG; urgent delivery consideration; prepare for emergency intervention.
• Absent or reversed EDV + reversed A-wave → Severe combined diastolic and atrial flow reversal; catastrophic hemodynamic failure. Action: IMMEDIATE EMERGENCY DELIVERY if ≥30 weeks; critical assessment if <30 weeks; prepare for resuscitation.
• Normal EDV + elevated PI/RI → Preserved diastolic velocity despite elevated resistance indices; may indicate compensatory mechanism or measurement variability. Action: Confirm measurements; serial monitoring; investigate for other causes.
Relationship between EDV, diastolic flow direction, and hemodynamic status:
The ductus venosus waveform reveals progressive hemodynamic derangement in stages:
• Stage 1 (Mild compromise): EDV reduced but positive; PI/RI elevated; A-wave normal.
• Stage 2 (Moderate compromise): EDV severely reduced (near-zero); PI/RI markedly elevated; A-wave diminished.
• Stage 3 (Severe/Critical compromise): Absent EDV (zero diastolic flow); reversed EDV (negative diastolic flow); A-wave normal or mildly reversed.
• Stage 4 (Catastrophic failure): Reversed EDV + reversed A-wave; complete flow reversal during diastole and atrial contraction; imminent fetal demise.
In severe IUGR with right heart dysfunction, the sequence often follows: reduced EDV → absent EDV → reversed EDV → reversed A-wave. Each stage represents progressive hemodynamic failure and warrants escalated clinical response.
Clinical Decision Thresholds (DV EDV Status)
DV EDV vs. DV PSV in IUGR Assessment:
• EDV is clinically superior to PSV in detecting and monitoring hemodynamic compromise because:
– EDV directly reflects afterload and vascular resistance (the primary pathology in IUGR).
– PSV may remain relatively preserved even in advanced IUGR; EDV deteriorates progressively.
– Absent or reversed EDV is always pathologic; absent/reversed PSV is rare.
– EDV trend is more sensitive to progressive hemodynamic deterioration.
• Combined PSV + EDV assessment provides complete picture:
– Normal PSV + reduced EDV = resistance elevation without systolic dysfunction (compensated).
– Reduced PSV + reduced/absent EDV = combined systolic and diastolic dysfunction (decompensated).
– Normal PSV + absent EDV = severe diastolic dysfunction with preserved systole (severe resistance).
– Reversed PSV + reversed EDV = catastrophic bidirectional flow reversal (imminent demise).
Key points to remember:
• DV EDV is an absolute velocity measurement primarily reflecting hepatic vascular resistance (the key pathology in IUGR).
• EDV is clinically more significant than PSV in IUGR assessment; EDV deterioration indicates worsening hemodynamic compromise.
• EDV progressively increases with advancing gestation (15 cm/s at 16 weeks to 40 cm/s at 42 weeks) reflecting falling hepatic resistance with fetal maturation.
• Reduced or absent EDV indicates elevated hepatic vascular resistance—the hallmark of IUGR with hemodynamic redistribution.
• Reversed EDV is a critical, time-sensitive finding indicating right atrial pressure elevation and right heart dysfunction; warrants URGENT delivery if ≥30 weeks.
• Absent + reversed EDV combination is catastrophic; indicates complete hemodynamic failure and imminent fetal demise risk.
• Angle correction is essential for EDV accuracy; maintain insonation angle <15° for optimal accuracy.
• Progressive EDV decline across serial scans is more clinically significant than a single reduced value; indicates worsening hemodynamic status.
• EDV deterioration occurs predictably before A-wave reversal; abnormal EDV warrants escalated surveillance even if A-wave still appears normal.
• Measure EDV on the proximal ductus venosus near IVC entry for standardization; mid or distal DV measurement yields different values.
• Fetal state matters: Measure during fetal quiescence; breathing movements and hiccoughs alter EDV and increase measurement variability.
• Absent or reversed EDV always warrants urgent clinical assessment; never defer decision-making with these findings.
• EDV provides earlier warning of hemodynamic decompensation than A-wave reversal; EDV abnormality should trigger escalated monitoring.
• Combine EDV assessment with PI/RI, A-wave, PSV, UA Doppler, and MCA Doppler for comprehensive hemodynamic picture.
• Never use EDV alone for delivery decisions; but absent or reversed EDV is a critical component of comprehensive assessment mandating urgent action.
MV (Mean Velocity) → Mean Velocity (MV) in Ductus Venosus is the average blood flow velocity calculated from the entire velocity envelope (from the beginning of systole through diastole and atrial contraction) in the ductus venosus waveform. It is an absolute velocity measurement expressed in cm/s, representing the mathematical average flow speed across the complete cardiac cycle and reflecting overall perfusion and cardiac output contribution.
Definition and calculation:
DV MV = Integrated area under the velocity-time envelope ÷ Duration of one cardiac cycle
(Automatically calculated by most modern ultrasound machines)
Relationship to other Doppler parameters:
Mean velocity is the mathematical denominator for calculating normalized resistance indices:
• Pulsatility Index (PI) = (S − D) ÷ MV — MV in denominator normalizes the S−D difference by mean flow.
• Resistance Index (RI) = (S − D) ÷ S — RI does not depend on MV.
• S/D Ratio = S ÷ D — S/D does not depend on MV.
This means MV is critical for PI calculation; changes in MV directly affect PI values even if S and D remain constant.
What DV MV measures:
Mean velocity reflects several hemodynamic factors:
• Cardiac output: MV increases with higher cardiac output (e.g., anemia, tachycardia, compensatory states).
• Vascular resistance and compliance: MV decreases when resistance rises or compliance falls (e.g., in IUGR, right heart dysfunction).
• Flow pulsatility: More pulsatile waveforms (high PI) generally have lower MV relative to PSV; flatter, less pulsatile waveforms have higher MV.
• Heart rate: Tachycardia may alter MV calculation; bradycardia lengthens the time integral.
• Fetal state and breathing: Breathing movements increase pulsatility and alter MV.
• Measurement angle: MV is angle-dependent; angle correction should be applied.
Clinical significance of DV MV:
Mean velocity alone has limited independent prognostic value in IUGR because it is influenced by multiple factors unrelated to resistance (heart rate, cardiac output, anemia, technique). However, MV becomes clinically significant in specific contexts:
• Reduced MV + elevated PI → Indicates both reduced flow perfusion AND elevated pulsatility; severe hemodynamic compromise.
• Reduced MV + normal PI → Reduced perfusion without pulsatility change; suggests reduced cardiac output or increased anemia without resistance elevation.
• Progressive MV decline across serial scans → Indicates worsening cardiac perfusion or output deterioration.
• Very low MV (< 10 cm/s) + reversed A-wave → Critical hemodynamic failure with severely reduced diastolic perfusion.
• MV trend combined with EDV trend → Both declining indicates progressive hemodynamic decompensation with reduced diastolic perfusion.
Measuring technique for DV MV:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava, avoiding the junction.
4. Angle correction is important for MV measurement: Align the Doppler beam as parallel as possible to the ductus venosus flow direction; maintain angle of insonation <15° for optimal accuracy; apply angle correction on the ultrasound machine for angles 0°–30°.
5. Measure during fetal rest (no breathing / movement); breathing movements distort the waveform and alter MV calculations.
6. Capture 3–4 uniform, representative waveforms during a stable, quiescent period. Avoid measuring during fetal hiccoughs or accelerations.
7. The ultrasound machine automatically traces the entire velocity envelope (the outer border of the Doppler signal from start of systole through completion of the cardiac cycle) and calculates mean velocity by integrating the area under the curve and dividing by cardiac cycle time.
8. Do not manually measure MV; rely on the machine's automated envelope tracing and calculation for accuracy.
9. Record the mean MV from 3–4 representative waveforms for reporting (express in cm/s).
10. Always measure MV in context of concurrent PSV, EDV, PI, RI, and A-wave assessment for complete hemodynamic evaluation.
11. Document angle of insonation, angle correction applied, sample volume position, technical quality, and fetal state for reproducibility.
Normal Mean Velocity Reference Values for Ductus Venosus by Gestational Age
Abnormal DV MV patterns and clinical significance:
• MV < 5th centile for GA (e.g., < 15 cm/s at 28 weeks) → Markedly reduced mean flow velocity. If concurrent normal or low PI, may indicate reduced cardiac output or anemia. If concurrent elevated PI, indicates both reduced perfusion AND elevated pulsatility; severe hemodynamic stress. Action: Assess hemoglobin; investigate cardiac function; serial monitoring every 3–7 days; CTG if ≥28 weeks.
• MV progressively declining across serial scans → Worsening cardiac perfusion or output deterioration. Action: Escalate surveillance; evaluate cardiac function; consider delivery if ≥32 weeks with concurrent abnormalities.
• Very low MV (< 10 cm/s) + elevated PI + reversed A-wave → Critical triad indicating severe perfusion failure, hemodynamic derangement, and imminent decompensation. Action: URGENT delivery if ≥32 weeks; immediate clinical assessment if <32 weeks.
• Low MV + low PI (both reduced) → Reduced perfusion with decreased pulsatility; unusual pattern suggesting reduced cardiac output without resistance elevation (possible anemia, hypovolemia, or cardiac dysfunction). Action: Assess hemoglobin and cardiac function; serial monitoring.
• Normal MV + elevated PI → Normal perfusion but elevated pulsatility; resistance elevation without acute perfusion failure. Action: Standard monitoring; deliver if ≥34 weeks with IUGR.
• Elevated MV + normal/low PI → Increased flow perfusion; may indicate compensatory high-output state (anemia, polycythemia). Action: Assess hemoglobin; routine monitoring if anemia confirmed.
MV's role in Pulsatility Index (PI) calculation:
Understanding the relationship between MV, S, D, and PI is critical:
• PI = (S − D) ÷ MV — If MV decreases while S and D remain constant, PI will increase (more pulsatile).
• PI = (S − D) ÷ MV — If MV increases while S and D remain constant, PI will decrease (less pulsatile).
• A waveform can have elevated PI for two reasons: (1) Large S−D difference (increased pulsatility from resistance elevation), or (2) Low MV (reduced overall perfusion).
• In severe IUGR, both mechanisms operate: S−D increases (resistance ↑) AND MV decreases (perfusion ↓), resulting in markedly elevated PI.
• Monitoring both MV and PI separately provides more complete hemodynamic information than PI alone.
Clinical Decision Framework (DV MV in Context)
MV in the context of PSV and EDV:
Complete hemodynamic assessment requires understanding all three velocity parameters:
• PSV high, EDV low, MV low: Highly pulsatile waveform; elevated resistance with reduced overall perfusion; severe IUGR pattern.
• PSV normal, EDV low, MV low: Diastolic-predominant resistance elevation; reduced diastolic perfusion; moderate IUGR pattern.
• PSV normal, EDV normal, MV normal: Normal triphasic waveform; no hemodynamic compromise; reassuring.
• PSV low, EDV low, MV very low: Globally reduced flow velocity; severe systolic and diastolic dysfunction; critical cardiac compromise.
• PSV high, EDV normal, MV normal: Exaggerated systolic peak; possible compensatory response; monitor for progression.
Key points to remember:
• DV Mean Velocity is an absolute velocity measurement reflecting perfusion and cardiac output contribution.
• MV alone has limited independent prognostic value; always interpret in context of PI/RI, PSV, EDV, and A-wave.
• MV is the mathematical foundation for PI calculation: PI = (S − D) ÷ MV; changes in MV directly affect PI values.
• MV progressively increases with advancing gestation (14 cm/s at 16 weeks to 39 cm/s at 42 weeks) reflecting rising fetal cardiac output.
• Reduced MV + elevated PI indicates severe hemodynamic compromise with both perfusion failure AND resistance elevation.
• Normal MV + elevated PI indicates preserved perfusion despite resistance elevation; less acutely concerning but still abnormal.
• Reduced MV + normal PI is uncommon and suggests reduced cardiac output without resistance change; investigate for cardiac dysfunction or anemia.
• Angle correction is important for MV accuracy; maintain insonation angle <15° for optimal accuracy.
• Progressive MV decline across serial scans is more clinically significant than a single reduced value; indicates worsening perfusion.
• Very low MV (< 10 cm/s) + reversed A-wave indicates critical hemodynamic failure; urgent action warranted.
• Fetal state matters: Measure during fetal quiescence; breathing movements distort the velocity envelope and alter MV calculations.
• Do not manually measure MV; always use machine-calculated values from automated envelope tracing.
• Elevated MV + normal PI + normal A-wave suggests high-output compensatory state; assess for anemia.
• Combine MV with PSV and EDV assessment to determine waveform shape and resistance pattern.
• Serial MV monitoring is valuable for detecting progressive deterioration; trend is more important than absolute value.
• MV provides additional hemodynamic context beyond PI/RI; separate reporting of MV enhances clinical assessment.
• MV should never be used as a sole criterion for clinical decisions; integrate with all available Doppler parameters and clinical context.
A-wave (Atrial Velocity) → A-wave (Atrial Velocity) in Ductus Venosus is the peak blood flow velocity occurring during right atrial contraction (atrial systole), represented as the third, smaller peak in the triphasic DV waveform that appears after the diastolic trough. It reflects right atrial contractility, right atrial afterload, and atrial-ventricular hemodynamic compatibility.
Definition and physiologic basis:
DV A-wave = Peak velocity during atrial contraction (expressed in cm/s or as a waveform characteristic)
The ductus venosus waveform consists of three velocity peaks across one cardiac cycle:
1. S-peak (Systolic): Blood flow surge during ventricular systole (right ventricle contracting); this is the largest peak.
2. D-trough (Diastolic): Blood flow decelerates during ventricular diastole (ventricle relaxing); this is the lowest point before atrial contraction begins.
3. A-peak (Atrial): Blood flow accelerates again during atrial contraction (right atrium contracting); this is the third smaller peak that occurs after diastole.
Under normal conditions, the A-wave is always positive (antegrade flow), indicating the atrium is effectively pushing blood forward toward the heart.
What DV A-wave measures:
The A-wave reflects several important hemodynamic factors:
• Right atrial contractility: A strong, prominent A-wave indicates robust atrial contraction; diminished A-wave suggests reduced atrial function.
• Right atrial afterload: A-wave velocity depends on the pressure gradient between the right atrium and the ductus venosus. Elevated right atrial pressure reduces A-wave velocity.
• Right ventricular diastolic function: Impaired RV diastolic compliance (stiffness) reduces the right atrium's ability to fill the ventricle and increases right atrial pressure, diminishing the A-wave.
• Tricuspid valve function: A-wave abnormalities may indicate tricuspid regurgitation, which elevates right atrial pressure.
• Atrial-ventricular pressure gradient: When right atrial pressure exceeds ductus venosus pressure, flow reverses, and the A-wave becomes negative (reversed A-wave).
• Fetal heart rate variability: Irregular heart rhythms (arrhythmias) can alter A-wave morphology; occasional dropped A-waves are normal.
Clinical significance of A-wave abnormalities:
The A-wave is the single most important DV Doppler marker of fetal hemodynamic compromise.
• Normal positive A-wave: Reassuring; indicates adequate right heart function.
• Diminished A-wave (reduced amplitude): Suggests mild right heart dysfunction or elevated right atrial pressure; warrants monitoring.
• Absent or barely visible A-wave: Indicates significant right atrial pressure elevation or severely reduced atrial contractility; concerning finding requiring urgent evaluation.
• Reversed A-wave (negative A-wave): CRITICAL FINDING. Indicates right atrial pressure exceeds ductus venosus pressure; severe right heart dysfunction or tricuspid regurgitation; blood flows backward during atrial contraction. Associated with high risk of imminent fetal decompensation, intrauterine fetal death, and perinatal death. Reversed A-wave alone justifies urgent delivery consideration if ≥32 weeks, even if other parameters are borderline.
• Oscillating or bizarre A-wave pattern: May indicate cardiac arrhythmia or severe hemodynamic instability.
Measuring technique for DV A-wave:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava.
4. Angle correction: Maintain angle of insonation <15° for optimal accuracy; apply angle correction if needed.
5. Measure during fetal rest (no breathing / movement); breathing movements distort the waveform and make A-wave assessment difficult.
6. Capture at least 4–5 cardiac cycles to ensure proper A-wave characterization; single cycles may miss A-wave abnormalities.
7. On the waveform display, identify the three-peak triphasic pattern:
– First large peak = S-peak (systole)
– Trough between peaks = D-trough (diastole)
– Second smaller peak after trough = A-peak (atrial contraction)
8. Assess A-wave direction and amplitude:
– Positive (upward) A-wave = Normal antegrade flow during atrial contraction
– Diminished A-wave = Reduced amplitude, barely visible above baseline
– Absent A-wave = No visible third peak; waveform appears biphasic (only S and D)
– Reversed A-wave = Downward (negative) deflection below baseline; flow reversal during atrial contraction
9. Most machines do not automatically measure A-wave velocity; A-wave is qualitatively assessed based on waveform appearance and direction. Some advanced systems display A-wave velocity in cm/s; if available, record it.
10. Classify A-wave status for reporting: Normal positive, Diminished, Absent, or Reversed.
11. Always assess A-wave in context of concurrent S, D, PI, RI, and clinical parameters for complete evaluation.
12. Document A-wave morphology, direction, regularity, sample volume position, fetal heart rate, and fetal state for reproducibility.
A-wave Classification and Reference Patterns for Ductus Venosus
Progressive stages of A-wave abnormality in IUGR:
The ductus venosus waveform typically deteriorates in a predictable sequence as fetal hemodynamic compromise worsens:
• Stage 1 (Mild compromise): S/D ratio elevated; PI/RI elevated; A-wave normal and positive.
• Stage 2 (Moderate compromise): S/D ratio further elevated; PI/RI markedly elevated; A-wave diminished in amplitude.
• Stage 3 (Severe compromise): Diastolic flow severely reduced or absent; PI/RI very high; A-wave barely visible or absent.
• Stage 4 (Critical/Catastrophic compromise): Reversed diastolic flow (reversed EDV); reversed A-wave; complete hemodynamic failure; imminent fetal demise risk.
Progression through these stages is not always linear; rapid deterioration can occur, particularly when reversed A-wave develops.
Clinical significance of reversed A-wave:
Reversed A-wave is one of the most ominous findings in fetal Doppler assessment. Multiple large prospective studies have demonstrated:
• Reversed A-wave has 70–100% sensitivity and 90–95% specificity for predicting adverse perinatal outcome in IUGR fetuses.
• Reversed A-wave is associated with an 8–10 fold increased risk of perinatal death compared to normal Doppler.
• Mean survival from reversed A-wave detection is approximately 2–7 days if expectant management continued in advanced IUGR.
• Delivery within 24–48 hours of reversed A-wave diagnosis significantly improves neonatal survival and reduces serious morbidity compared to delayed delivery.
• Reversed A-wave predicts outcome better than any other single Doppler parameter, including absent diastolic flow in umbilical artery.
Clinical Decision Thresholds (DV A-wave Status)
A-wave in integrated Doppler assessment:
The A-wave must always be interpreted as part of complete hemodynamic evaluation:
• Normal S/D/PI + Normal A-wave = Reassuring; no hemodynamic compromise.
• Elevated S/D/PI + Normal A-wave = Resistance elevation without acute right heart dysfunction (early IUGR).
• Elevated S/D/PI + Diminished A-wave = Progressive hemodynamic compromise; right heart dysfunction developing.
• Elevated S/D/PI + Absent A-wave = Advanced hemodynamic failure; urgent intervention needed.
• Elevated S/D/PI + Reversed A-wave = Critical hemodynamic failure; URGENT delivery if ≥32 weeks.
• Normal S/D/PI + Reversed A-wave = Unusual; indicates isolated right heart dysfunction or tricuspid pathology; warrants cardiac assessment.
• Absent EDV + Reversed A-wave = Catastrophic hemodynamic failure; dual flow reversal (diastole + atrial contraction); highest risk.
Key points to remember:
• A-wave is the most clinically significant DV Doppler parameter and the single best marker of fetal hemodynamic compromise.
• Normal positive A-wave is reassuring; indicates adequate right heart function regardless of other Doppler abnormalities.
• Diminished A-wave indicates early right heart dysfunction; warrants escalated surveillance every 3–7 days.
• Absent A-wave is concerning; indicates significant hemodynamic failure; demands urgent clinical assessment and consideration of delivery if ≥32 weeks.
• REVERSED A-wave is a CRITICAL, TIME-URGENT finding that represents imminent fetal decompensation and high perinatal mortality risk.
• Reversed A-wave alone justifies urgent delivery consideration at ≥32 weeks, even if other parameters are borderline. Do not delay delivery for confirmatory testing.
• Reversed A-wave has 70–100% sensitivity and 90–95% specificity for adverse outcome in IUGR; associated with 8–10 fold increased mortality risk.
• Mean survival time after reversed A-wave detection is 2–7 days; delivery within 24–48 hours significantly improves survival.
• A-wave abnormalities may precede other signs of fetal distress (abnormal CTG, biometric growth restriction, oligohydramnios); A-wave is early warning signal.
• Always assess A-wave in context of concurrent S, D, PI, RI, EDV, and clinical parameters for complete hemodynamic picture.
• A-wave abnormality combined with reversed EDV or absent EDV is catastrophic; indicates dual flow reversal and imminent demise.
• Measure A-wave during fetal rest/quiescence; breathing movements and arrhythmias distort waveform assessment.
• Obtain at least 4–5 cardiac cycles for proper A-wave characterization; single cycles may miss abnormalities.
• A-wave should be qualitatively classified (normal/diminished/absent/reversed); most machines do not provide automated A-wave velocity measurements.
• Progressive A-wave deterioration across serial scans indicates accelerating hemodynamic decompensation; warrants urgent action.
• Reversed A-wave is independent of delivery mode; both vaginal and cesarean delivery are acceptable if urgent delivery indicated.
• Communication with neonatal team is essential when reversed A-wave diagnosed; prepare for potential intensive neonatal care needs.
• Never attribute reversed A-wave to arrhythmia or technical error without careful assessment; when in doubt, repeat scan promptly and consider urgent delivery planning.
S/D ratio → S/D ratio (Systolic/Diastolic ratio) in Ductus Venosus is the ratio of peak systolic velocity (S) to peak diastolic velocity (D) in the ductus venosus waveform. It reflects hepatic vascular resistance and fetal hemodynamic status.
Formula:
DV S/D ratio = Peak Systolic Velocity (S) ÷ Peak Diastolic Velocity (D)
What it measures:
The ductus venosus carries oxygenated, nutrient-rich umbilical venous blood. Under normal conditions, the DV displays a characteristic triphasic waveform with flow in systole (S), diastole (D), and atrial contraction (A-wave). The S/D ratio reflects the change in hepatic vascular resistance and cardiac performance across the cardiac cycle. In normal fetuses, systolic flow is highest, diastolic flow remains positive, and the S/D ratio is relatively stable across gestation. In fetal compromise—particularly severe IUGR with placental insufficiency or right heart dysfunction—vascular resistance rises, diastolic flow decreases, and the S/D ratio increases. In severe cases, diastolic and/or atrial flows become reversed (negative), indicating critical hemodynamic derangement and imminent fetal decompensation.
• 20 weeks: ~3.0–3.5
• 28 weeks: ~2.8–3.2
• 34 weeks: ~2.5–3.0
• 40 weeks: ~2.3–2.8
Measuring technique for DV S/D:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava.
4. Maintain angle of insonation close to 0° for accurate velocity measurement.
5. Measure during fetal rest (no breathing / movement), capture at least 3 uniform waveforms.
6. On each waveform, identify three peaks: S (systolic peak), D (diastolic peak), and A (atrial contraction peak).
7. Most machines auto-calculate S/D, RI, and PI; record the mean of 3 waveforms for reporting.
8. Note the presence, direction, and magnitude of A-wave flow; reversed A-wave is a critical finding.
Normal S/D Ratio Reference Values for Ductus Venosus by Gestational Age
| GA (weeks) | S/D Ratio (5th–95th centile) | DV PI (5th–95th centile) | Interpretation |
|---|---|---|---|
| 16 | 3.2–3.8 | 0.60–0.85 | Early second trimester baseline |
| 18 | 3.1–3.7 | 0.58–0.82 | Progressive stabilization |
| 20 | 3.0–3.6 | 0.55–0.80 | Normal reference point |
| 22 | 2.95–3.5 | 0.52–0.78 | Gradual decline in S/D |
| 24 | 2.9–3.4 | 0.50–0.75 | Stable hemodynamics |
| 26 | 2.85–3.3 | 0.48–0.72 | Continued maturation |
| 28 | 2.8–3.2 | 0.45–0.70 | Diastolic flow stable |
| 30 | 2.75–3.1 | 0.42–0.68 | — |
| 32 | 2.7–3.0 | 0.40–0.65 | — |
| 34 | 2.6–2.95 | 0.38–0.62 | Late third trimester |
| 36 | 2.5–2.9 | 0.36–0.60 | — |
| 38 | 2.45–2.85 | 0.34–0.58 | — |
| 40 | 2.4–2.8 | 0.32–0.55 | Term reference values |
| 41–42 | 2.35–2.75 | 0.30–0.53 | Post-term stable values |
Abnormal patterns:
• S/D > 95th centile for GA → Elevated hepatic vascular resistance; reduced diastolic flow. Indicates placental insufficiency, IUGR, or cardiac dysfunction.
• S/D progressively increasing across serial scans → Worsening hepatic resistance and fetal compromise; risk of decompensation.
• Absent or severely reduced diastolic flow in DV → Critical hemodynamic deterioration; imminent fetal decompensation risk.
• Reversed A-wave (atrial contraction showing reversed flow) → Sign of severe fetal compromise, right heart dysfunction, or tricuspid regurgitation. Associated with high perinatal mortality risk; urgent delivery consideration if ≥34 weeks.
• Reversed S-wave (rarely occurs) → Extreme hemodynamic derangement; immediate delivery consideration.
Prognostic value of DV Doppler abnormalities:
The ductus venosus Doppler is among the most sensitive markers of fetal hemodynamic compromise. Abnormal DV waveforms, particularly reversed A-waves, carry a high predictive value for adverse perinatal outcome in IUGR fetuses. DV assessment is especially valuable in early-onset IUGR (before 32 weeks), where it guides delivery timing and helps differentiate constitutionally small fetuses from those with true placental insufficiency.
Clinical Decision Thresholds (DV S/D and PI)
| DV Doppler Finding | Hepatic Vascular Resistance | Clinical Interpretation | Clinical Action |
|---|---|---|---|
| S/D and PI within normal for GA; positive A-wave | Normal | Normal fetal hemodynamics | Routine surveillance |
| S/D or PI > 95th centile; positive A-wave | Elevated | Mild to moderate hepatic resistance; early IUGR or placental insufficiency | Confirm IUGR status with growth assessment; serial Doppler every 3–7 days |
| S/D and PI markedly elevated; diastolic flow reduced | Severely elevated | Significant placental insufficiency; advanced IUGR | Daily CTG if ≥28 weeks; assess delivery feasibility; high risk of perinatal compromise |
| Absent or reversed diastolic flow in DV | Critical resistance | Critical hemodynamic derangement; imminent fetal decompensation | Urgent delivery if ≥34 weeks; consider steroid prophylaxis; neonatal resuscitation standby |
| Reversed A-wave (negative atrial flow) | Right heart dysfunction | Severe fetal compromise; tricuspid regurgitation or right atrial pressure elevation | URGENT delivery if ≥32 weeks; if <32 weeks, daily CTG; hospitalize; consider transfer to tertiary centre |
| Reversed S-wave (extremely rare) | Extreme derangement | Imminent fetal demise or severe cardiac pathology | IMMEDIATE delivery regardless of GA (if viable) |
Key points to remember:
• DV S/D ratio and PI are slowly declining with advancing gestation, but changes are subtle. Focus on trend and absolute deviation from centiles, not minor variations.
• The A-wave (atrial contraction wave) is the most clinically important component of the DV waveform; always assess its presence and direction.
• Reversed or absent A-wave is a critical finding indicating severe compromise and elevated perinatal mortality risk—demands urgent clinical decision-making.
• DV Doppler is particularly valuable in early-onset IUGR (before 32 weeks) where it helps guide delivery timing and predicts outcome better than umbilical artery Doppler alone.
• Always interpret DV findings in context of concurrent UA and MCA Doppler (Doppler index concept) and fetal biometry.
• PI is preferred over S/D ratio for DV assessment in modern practice, as it is more standardized and angle-independent.
• Measure on the proximal ductus venosus near entry into the IVC; sampling from the mid or distal DV may yield spurious results.
• Ensure angle correction is applied (maintain 0° angle) or use angle-independent indices (PI, RI).
• Absent or reversed DV flow patterns warrant delivery planning within 24–48 hours (or immediately if <34 weeks with other signs of compromise).
• Combine DV with umbilical artery and MCA assessment to construct the complete hemodynamic picture: elevated UA + elevated DV + reduced MCA = severe IUGR with decompensation.
RI (Resistance Index) → RI (Resistance Index) in Ductus Venosus is a normalized, angle-independent Doppler index that quantifies vascular resistance by measuring the relationship between peak systolic velocity (S), end-diastolic velocity (D), and mean velocity (MV). It reflects hepatic vascular resistance and fetal hemodynamic status more reliably than S/D ratio alone.
Formula:
DV RI = (Peak Systolic Velocity − End-Diastolic Velocity) ÷ Peak Systolic Velocity
DV RI = (S − D) ÷ S
Advantages of RI over S/D ratio:
The Resistance Index offers several clinical advantages:
• Angle-independent: RI is mathematically normalized and remains valid across angle variations (0° to 60°), whereas S/D is angle-dependent.
• Normalizes resistance: RI expresses resistance as a proportion of systolic velocity, providing a standardized measure comparable across different vessels and time points.
• Remains valid at extreme resistances: Unlike S/D, which becomes mathematically invalid or unreliable when diastolic flow approaches zero or reverses, RI handles absent/reversed diastolic and atrial flows mathematically (RI can reach 1.0 at zero diastolic flow, and technically exceed 1.0 with reversed flow).
• Better reproducibility: RI shows improved inter-observer and intra-observer agreement, making it preferred for serial monitoring and quality assurance.
• Standardized centiles: Most modern Doppler reference databases provide age-specific RI centiles; RI-based decisions align with current guidelines and research.
What DV RI measures:
The ductus venosus carries oxygenated, nutrient-rich umbilical venous blood. Under normal conditions, the DV displays a characteristic triphasic waveform with flow in systole (S), diastole (D), and atrial contraction (A-wave). The RI reflects the change in hepatic vascular resistance and cardiac performance across the cardiac cycle. In normal fetuses, systolic flow is highest, diastolic and atrial flows remain positive, and the RI is relatively stable across gestation, ranging from approximately 0.50–0.70. In fetal compromise—particularly severe IUGR with placental insufficiency or right heart dysfunction—vascular resistance rises, diastolic flow decreases, RI increases, and the waveform flattens. In severe cases, diastolic and/or atrial flows become reversed (negative), RI approaches or exceeds 1.0, indicating critical hemodynamic derangement and imminent fetal decompensation.
• 16–20 weeks: ~0.60–0.75 (normal baseline)
• 24–28 weeks: ~0.55–0.70 (stable mid-gestation)
• 32–36 weeks: ~0.50–0.65 (late trimester maturation)
• 38–42 weeks: ~0.48–0.62 (term values)
Measuring technique for DV RI:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava, avoiding the junction to prevent artifacts.
4. Maintain angle of insonation as close to 0° as possible (though RI is more forgiving of angle error than S/D).
5. Measure during fetal rest (no breathing / movement); avoid fetal breathing movements which distort the waveform.
6. Capture at least 3–4 uniform, representative waveforms during a stable, quiescent period.
7. On each waveform, identify: S (systolic peak), D (end-diastolic point), and calculate mean velocity (MV) from the velocity envelope.
8. Most ultrasound machines automatically calculate RI; record the mean RI from 3–4 waveforms for reporting.
9. Always note the presence, direction, and appearance of the A-wave (atrial contraction wave); reversed A-wave is a critical finding even if RI is mildly abnormal.
10. Document sample volume position, angle, and technical quality to ensure reproducibility for serial measurements.
Normal RI Reference Values for Ductus Venosus by Gestational Age
| GA (weeks) | DV RI (5th–95th centile) | DV S/D Ratio (5th–95th centile) | Interpretation |
|---|---|---|---|
| 16 | 0.62–0.78 | 3.2–3.8 | Early second trimester baseline |
| 18 | 0.60–0.76 | 3.1–3.7 | Progressive stabilization |
| 20 | 0.58–0.74 | 3.0–3.6 | Normal reference point |
| 22 | 0.57–0.72 | 2.95–3.5 | Gradual decline in RI |
| 24 | 0.55–0.70 | 2.9–3.4 | Stable hemodynamics |
| 26 | 0.54–0.68 | 2.85–3.3 | Continued maturation |
| 28 | 0.52–0.66 | 2.8–3.2 | Diastolic flow stable |
| 30 | 0.50–0.64 | 2.75–3.1 | Progressive decline |
| 32 | 0.49–0.62 | 2.7–3.0 | Late third trimester |
| 34 | 0.48–0.61 | 2.6–2.95 | Approaching term values |
| 36 | 0.47–0.59 | 2.5–2.9 | — |
| 38 | 0.46–0.58 | 2.45–2.85 | — |
| 40 | 0.45–0.57 | 2.4–2.8 | Term reference values |
| 41–42 | 0.44–0.56 | 2.35–2.75 | Post-term stable values |
Abnormal RI patterns and clinical significance:
• DV RI > 95th centile for GA → Elevated hepatic vascular resistance; reduced diastolic flow. Indicates placental insufficiency, IUGR, or early cardiac dysfunction. Action: Confirm IUGR status; serial Doppler monitoring every 3–7 days.
• DV RI > 0.70 at term (or > 95th centile) → Significant resistance elevation; warrants investigation for IUGR, growth restriction, or cardiac anomaly.
• DV RI progressively increasing across serial scans → Worsening hepatic resistance and deteriorating fetal hemodynamics; risk of acute decompensation. Action: Consider delivery if ≥34 weeks; escalate surveillance.
• RI approaching or reaching 1.0 → Severely reduced or absent diastolic flow; critical hemodynamic derangement.
• RI > 1.0 or calculation impossible → Diastolic flow is reversed (negative), indicating reversed flow during diastole or atrial contraction. This reflects critical right heart dysfunction or severe tricuspid regurgitation. Action: URGENT delivery consideration if ≥34 weeks; immediate clinical assessment if <34 weeks.
• Reversed or absent A-wave with RI > 95th centile → Combination finding indicating severe fetal compromise with right atrial pressure elevation or tricuspid valve insufficiency. Action: URGENT evaluation; delivery planning within 24–48 hours if ≥32 weeks.
Prognostic value of DV RI abnormalities:
The ductus venosus RI is among the most sensitive and specific markers of fetal hemodynamic compromise. Abnormal DV RI, particularly when combined with reversed A-waves or reversed diastolic flow, carries a high predictive value for adverse perinatal outcome in IUGR fetuses. DV assessment is especially valuable in early-onset IUGR (before 32 weeks), where it guides delivery timing, predicts outcome better than umbilical artery Doppler alone, and helps differentiate constitutionally small fetuses from those with true placental insufficiency and hemodynamic compromise.
Clinical Decision Thresholds (DV RI)
| DV RI Finding | Hepatic Vascular Resistance | Fetal Hemodynamic Status | Clinical Interpretation | Clinical Action |
|---|---|---|---|---|
| RI within 5th–95th centile for GA; positive A-wave | Normal | Compensated | Normal fetal hemodynamics | Routine antenatal care; standard surveillance intervals |
| RI > 95th centile but < 1.0; positive A-wave | Mildly to moderately elevated | Early compensation | Mild to moderate placental insufficiency or IUGR; early hemodynamic stress | Confirm biometric IUGR; assess UA Doppler; serial DV RI every 3–7 days; consider delivery if ≥34 weeks with other abnormalities |
| RI significantly elevated (e.g., > 0.75 at term); reduced diastolic flow | Severely elevated | Advanced compensation | Significant placental insufficiency; advanced IUGR with hemodynamic derangement | Daily CTG if ≥28 weeks; assess growth parameters and other vessel Doppler; consider delivery if ≥32 weeks; high risk of perinatal morbidity |
| RI approaching 1.0; absent or severely reduced diastolic flow | Critical resistance | Decompensation imminent | Critical hemodynamic failure; imminent fetal decompensation | URGENT delivery if ≥32–34 weeks; if <32 weeks, daily CTG, hospitalize, transfer to tertiary centre; neonatal resuscitation standby |
| RI > 1.0 or reversed diastolic flow | Reversed resistance gradient | Critical decompensation | Reversed flow during diastole; severe right heart dysfunction or tricuspid regurgitation | IMMEDIATE delivery if ≥32 weeks; critical emergency if <32 weeks; dual obstetric-neonatal team management; prepare for resuscitation |
| Reversed A-wave (negative atrial flow) with elevated RI | Right atrial pressure elevation | Critical failure | Reversed atrial contraction flow; tricuspid insufficiency; right atrial pressure exceeds ductus venosus pressure | URGENT/EMERGENT delivery; ≥34 weeks = deliver within 24 hrs; <34 weeks = urgent tertiary referral, dual team management; perinatal mortality risk very high |
Key points to remember:
• DV RI is angle-independent and normalized—superior to S/D ratio for serial monitoring and quality assurance.
• DV RI slowly declines with advancing gestation, but changes are subtle; focus on trend and absolute deviation from age-specific centiles, not minor variations.
�� The A-wave (atrial contraction wave) is clinically crucial; always assess its presence, direction, and amplitude.
• Reversed or absent A-wave is a critical, time-sensitive finding indicating severe compromise and elevated perinatal mortality—demands urgent clinical decision-making even if RI is borderline.
• RI ≥ 1.0 or reversed diastolic flow is a medical emergency; coordinate immediate obstetric and neonatal planning.
• DV RI is particularly valuable in early-onset IUGR (before 32 weeks) where it predicts outcome better than umbilical artery Doppler alone.
• Always interpret DV findings in context of concurrent UA (umbilical artery) and MCA (middle cerebral artery) Doppler and fetal growth parameters.
• Doppler index concept: Elevated UA RI + elevated DV RI + reduced MCA RI = severe IUGR with hemodynamic decompensation.
• Measure on the proximal ductus venosus near entry into the IVC; sampling from mid or distal DV may yield spurious results.
• Ensure adequate angle correction is applied (maintain 0° angle when possible), although RI is more forgiving of angle variations than S/D.
• Serial DV monitoring is essential; a single abnormal value requires confirmation and trend assessment before major clinical decisions.
• DV RI deterioration (progressive increase) across repeated scans is often more clinically significant than a single abnormal value.
• In borderline cases (RI at 90th–95th centile), combine DV RI assessment with CTG, growth parameters, and other vessel Doppler indices before deciding on intervention.
PI (Pulsatility Index) → PI (Pulsatility Index) in Ductus Venosus is a normalized, angle-independent Doppler index that quantifies vascular resistance and blood flow pulsatility by measuring the relationship between peak systolic velocity (S), end-diastolic velocity (D), and mean velocity (MV) across the entire cardiac cycle. It reflects hepatic vascular resistance, venous compliance, and right heart function more comprehensively than S/D ratio or RI alone.
Formula:
DV PI = (Peak Systolic Velocity − End-Diastolic Velocity) ÷ Mean Velocity
DV PI = (S − D) ÷ MV
Advantages of PI over S/D ratio and RI:
The Pulsatility Index offers multiple clinical advantages and is now the preferred primary Doppler index in most modern centres:
• Angle-independent: PI is mathematically normalized and remains valid across angle variations (0° to 60°), accounting for the entire flow profile.
• Accounts for mean velocity: Unlike S/D and RI which use only peak and diastolic components, PI incorporates mean velocity from the entire velocity envelope, providing a more complete hemodynamic assessment.
• Normalizes pulsatility: PI expresses the difference between systolic and diastolic components as a proportion of mean velocity, providing a standardized measure of vascular resistance, compliance, and afterload.
• Remains valid at extreme resistances: PI is mathematically sound even when diastolic flow approaches zero or reverses (though interpretation requires concurrent A-wave assessment).
• Superior prognostic value: PI shows stronger correlation with adverse perinatal outcomes in IUGR compared to S/D ratio and superior reproducibility compared to RI.
• Better reproducibility: PI demonstrates excellent inter-observer and intra-observer agreement, making it the gold standard for serial monitoring.
• Standardized centiles globally: Most major Doppler reference databases (GSPOD, KANET, etc.) provide age-specific PI centiles; PI-based decisions align with current international guidelines and research.
• Single comprehensive index: PI captures both resistance and compliance changes, reducing need for multiple indices in clinical practice.
What DV PI measures:
The ductus venosus carries oxygenated, nutrient-rich umbilical venous blood under low-resistance, high-compliance conditions. Under normal conditions, the DV displays a characteristic triphasic waveform with flow in systole (S), diastole (D), and atrial contraction (A-wave), with relatively small pulsatile variations proportional to cardiac afterload. The PI reflects the combination of hepatic vascular resistance and the pulsatile energy transmitted from the right heart through the venous system. In normal fetuses, PI is relatively stable across gestation (approximately 0.40–0.85), reflecting consistent venous compliance and afterload. In fetal compromise—particularly severe IUGR with placental insufficiency or right heart dysfunction—vascular resistance and afterload rise, diastolic and atrial flows decrease, the waveform becomes more pulsatile, and PI increases. In severe cases, diastolic and/or atrial flows become reversed (negative), PI continues to rise, indicating critical hemodynamic derangement and imminent fetal decompensation.
• 16–20 weeks: ~0.60–0.85 (normal baseline)
• 24–28 weeks: ~0.50–0.75 (stable mid-gestation)
• 32–36 weeks: ~0.42–0.68 (late trimester maturation)
• 38–42 weeks: ~0.38–0.65 (term values)
Measuring technique for DV PI:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava, avoiding the junction to prevent artifacts.
4. Maintain angle of insonation as close to 0° as possible (though PI is more forgiving of angle error than S/D).
5. Measure during fetal rest (no breathing / movement); avoid fetal breathing movements which distort the waveform and increase pulsatility variability.
6. Capture at least 3–4 uniform, representative waveforms during a stable, quiescent period. Avoid measuring during fetal hiccoughs or acelerations.
7. On each waveform, the ultrasound machine traces the velocity envelope (outer border of the Doppler signal) and automatically calculates S (systolic peak), D (end-diastolic point), and MV (mean velocity).
8. Most modern ultrasound machines automatically calculate and display PI; record the mean PI from 3–4 representative waveforms for reporting.
9. Always note the presence, direction, and appearance of the A-wave (atrial contraction wave); reversed or diminished A-wave is a critical finding and must be documented separately.
10. Document sample volume position, angle, technical quality, fetal state (quiescent vs. active), and any technical limitations to ensure reproducibility for serial measurements.
Normal PI Reference Values for Ductus Venosus by Gestational Age
| GA (weeks) | DV PI (5th–95th centile) | DV RI (5th–95th centile) | DV S/D Ratio (5th–95th centile) | Interpretation |
|---|---|---|---|---|
| 16 | 0.66–0.88 | 0.62–0.78 | 3.2–3.8 | Early second trimester baseline |
| 18 | 0.64–0.86 | 0.60–0.76 | 3.1–3.7 | Progressive stabilization |
| 20 | 0.62–0.84 | 0.58–0.74 | 3.0–3.6 | Normal reference point |
| 22 | 0.60–0.82 | 0.57–0.72 | 2.95–3.5 | Gradual decline in PI |
| 24 | 0.58–0.80 | 0.55–0.70 | 2.9–3.4 | Stable hemodynamics |
| 26 | 0.56–0.78 | 0.54–0.68 | 2.85–3.3 | Continued maturation |
| 28 | 0.54–0.76 | 0.52–0.66 | 2.8–3.2 | Diastolic flow stable |
| 30 | 0.52–0.74 | 0.50–0.64 | 2.75–3.1 | Progressive decline |
| 32 | 0.50–0.72 | 0.49–0.62 | 2.7–3.0 | Late third trimester |
| 34 | 0.48–0.70 | 0.48–0.61 | 2.6–2.95 | Approaching term values |
| 36 | 0.46–0.68 | 0.47–0.59 | 2.5–2.9 | — |
| 38 | 0.44–0.66 | 0.46–0.58 | 2.45–2.85 | — |
| 40 | 0.42–0.64 | 0.45–0.57 | 2.4–2.8 | Term reference values |
| 41–42 | 0.40–0.62 | 0.44–0.56 | 2.35–2.75 | Post-term stable values |
Abnormal PI patterns and clinical significance:
• DV PI > 95th centile for GA → Elevated hepatic vascular resistance and increased pulsatility; reduced diastolic flow. Indicates placental insufficiency, IUGR, or early cardiac dysfunction. Action: Confirm IUGR status with biometry; assess UA and MCA Doppler; serial DV PI every 3–7 days.
• DV PI > 0.70 at term (or > 95th centile) → Significant resistance elevation and waveform distortion; warrants investigation for IUGR, growth restriction, or cardiac/venous anomaly.
• DV PI progressively increasing across serial scans → Worsening hepatic resistance, increasing afterload, and deteriorating fetal hemodynamics; high risk of acute decompensation. Action: Consider delivery if ≥34 weeks; escalate surveillance to twice-weekly CTG; assess umbilical artery Doppler.
• DV PI markedly elevated (e.g., > 1.0 at term) → Severely elevated pulsatility; critically reduced diastolic flow; hemodynamic derangement. Action: URGENT assessment; consider delivery if ≥32 weeks; evaluate cardiac function.
• DV PI with reversed A-wave (abnormal atrial flow) → Elevated PI combined with reversed/absent atrial contraction flow is a critical marker of severe hemodynamic failure, indicating right atrial pressure elevation or tricuspid insufficiency. Action: URGENT delivery consideration if ≥32 weeks; immediate clinical assessment.
• Rapidly rising DV PI (steep trend) → Progressive waveform deterioration indicating acute hemodynamic decompensation risk. Action: Daily CTG; urgent delivery consideration if ≥30 weeks; transfer to tertiary centre if <32 weeks.
Prognostic value of DV PI abnormalities:
The ductus venosus PI is among the most sensitive and specific markers of fetal hemodynamic compromise and is now considered the gold standard venous Doppler index in modern perinatology. Abnormal DV PI, particularly when combined with reversed A-waves or progressive elevation, carries a high predictive value for adverse perinatal outcome in IUGR fetuses. DV PI assessment is especially valuable in early-onset IUGR (before 32 weeks), where it guides delivery timing with greater precision than umbilical artery Doppler alone, predicts intrauterine fetal death (IFOD) and neonatal death better than arterial indices, and helps differentiate constitutionally small fetuses from those with true placental insufficiency and hemodynamic decompensation. Reversed DV A-wave is an independent marker of poor perinatal outcome and warrants delivery planning within 24–48 hours at ≥32 weeks.
Clinical Decision Thresholds (DV PI)
| DV PI Finding | Hepatic Vascular Resistance & Pulsatility | Fetal Hemodynamic Status | Clinical Interpretation | Clinical Action |
|---|---|---|---|---|
| PI within 5th–95th centile for GA; normal triphasic A-wave | Normal | Compensated; normal | Normal fetal hemodynamics and venous function | Routine antenatal care; standard surveillance intervals (3–4 weeks) |
| PI > 95th centile but < 0.70; positive A-wave present | Mildly to moderately elevated | Early compensation | Mild to moderate placental insufficiency or early IUGR; subtle hemodynamic stress | Confirm biometric IUGR; assess UA PI and MCA PI; serial DV PI every 3–7 days; CTG if ≥28 weeks; consider delivery if ≥34 weeks with concurrent abnormalities |
| PI 0.70–0.80 at term; diminished diastolic/A-wave | Significantly elevated | Advanced compensation | Significant placental insufficiency; IUGR with progressive hemodynamic derangement | Twice-weekly CTG if ≥28 weeks; comprehensive UA, MCA, DV assessment; hospitalize; consider delivery if ≥32 weeks; neonatal team standby if ≥34 weeks |
| PI > 0.80 or markedly elevated; reduced/absent diastolic flow | Severely elevated pulsatility | Decompensation imminent | Critical hemodynamic failure; venous pressure elevation; imminent fetal decompensation risk | URGENT delivery if ≥34 weeks; if 30–33 weeks, daily CTG, hospitalize, urgent tertiary referral; if <30 weeks, intensive counselling, dual obstetric-neonatal team; neonatal resuscitation standby |
| DV PI with reversed A-wave (negative atrial flow) | Critical venous hypertension | Critical decompensation | Reversed atrial contraction flow; right atrial pressure exceeds ductus venosus pressure; severe right heart dysfunction or tricuspid regurgitation | URGENT/EMERGENT delivery; ≥32 weeks = deliver within 24 hrs; 28–31 weeks = urgent tertiary referral with dual team; <28 weeks = intensive counselling regarding viability and neonatal outcome; high perinatal mortality risk |
| DV PI rapidly increasing trend (steepening curve) | Progressively deteriorating | Acute decompensation risk | Waveform deterioration over days; high risk of acute hemodynamic collapse | Daily CTG; assess fetal movement; urgent delivery consideration at ≥30 weeks; intensive monitoring if <30 weeks; prepare for emergency intervention |
DV PI Combined with Other Doppler Indices (Doppler Index Concept):
Modern IUGR surveillance uses integrated Doppler assessment combining multiple vessel indices:
• Elevated UA PI + Elevated DV PI + Reduced MCA PI = Severe IUGR with hemodynamic redistribution; high-risk group requiring close monitoring and delivery planning.
• Normal UA PI + Elevated DV PI = Right heart dysfunction or primary venous disease (rare); requires cardiac evaluation.
• Elevated UA PI + Normal DV PI + Normal MCA PI = Mild placental insufficiency; lower imminent risk; continue standard surveillance.
• Elevated UA PI + Normal DV PI + Reduced MCA PI = Brain-sparing effect without venous involvement; intermediate risk.
Key points to remember:
• DV PI is angle-independent, normalized, and comprehensive—now the preferred primary DV index in modern centres; use in preference to S/D ratio.
• DV PI incorporates mean velocity from the entire cardiac cycle, providing superior hemodynamic assessment compared to S/D or RI alone.
• DV PI slowly declines with advancing gestation; focus on trend and centile deviation rather than absolute values.
• The A-wave (atrial contraction wave) is clinically crucial; always assess its presence, direction, amplitude, and trend. Reversed A-wave is a critical finding even if PI is borderline abnormal.
• Reversed or absent A-wave with abnormal PI is a time-sensitive, urgent marker of severe hemodynamic failure requiring delivery planning.
• DV PI is particularly valuable in early-onset IUGR (before 32 weeks) where it predicts adverse outcome better than arterial indices and guides delivery decisions.
• Progressive DV PI elevation (steep trend across serial scans) is often more clinically significant than a single abnormal value; implies decompensation risk.
• Always interpret DV PI in context of concurrent UA PI (umbilical artery) and MCA PI (middle cerebral artery) Doppler and fetal growth parameters.
• Doppler index concept: Integrated assessment of UA, DV, and MCA indices provides superior prediction of adverse outcome compared to single-vessel assessment.
• Measure on the proximal ductus venosus near entry into the IVC; avoid mid or distal DV sampling which may yield spurious results.
• Fetal state matters: Measure during fetal quiescence; avoid measurement during breathing movements or hiccoughs which artificially increase PI.
• Serial DV monitoring is essential; establish a baseline and trend; a single abnormal PI requires confirmation and context before major decisions.
• In borderline cases (PI at 90th–95th centile), combine DV PI assessment with CTG, growth velocity, UA Doppler, and other parameters before deciding on intervention.
• DV PI combined with abnormal venous waveform morphology (flattened diastole, absent A-wave) indicates high-risk hemodynamic state warranting urgent action.
PSV (Peak Systolic Velocity) → PSV (Peak Systolic Velocity) in Ductus Venosus is the maximum blood flow velocity recorded in the ductus venosus waveform during the systolic (ventricular contraction) phase of the cardiac cycle. It is an absolute velocity measurement expressed in cm/s, representing the peak instantaneous flow speed during right ventricular systole.
Definition and measurement:
DV PSV = The highest point on the Doppler waveform during systole, measured in cm/s
What DV PSV measures:
PSV is a direct measure of peak flow velocity, which is influenced by:
• Right heart contractility: PSV increases with stronger ventricular contraction and cardiac output.
• Hepatic afterload: PSV decreases when hepatic vascular resistance rises (e.g., in liver congestion or cirrhosis—rare in fetuses).
• Circulating blood volume: PSV may decrease with fetal anemia or hypovolemia, and increase with polycythemia.
• Angle of insonation: PSV is angle-dependent; measurements at angle >30° become unreliable. Always apply angle correction or maintain angle <15°.
• Transducer position and technique: Slight changes in sample volume position along the DV can alter PSV; standardized measurement technique is essential.
Clinical significance of DV PSV:
Unlike normalized indices (PI, RI) which reflect resistance independent of flow, PSV provides information about absolute flow speed and cardiac output. PSV alone has limited independent prognostic value in IUGR assessment because it can vary widely based on multiple factors unrelated to hemodynamic compromise (angle, technique, cardiac output state). However, PSV becomes clinically significant in specific contexts:
• Markedly reduced PSV + abnormal PI/RI → Indicates severe hemodynamic deterioration with reduced cardiac output.
• Progressive decline in PSV across serial scans → Suggests worsening right heart function or cardiac output.
• Severely reduced PSV + reversed A-wave → Critical hemodynamic failure with reduced systolic function.
• Elevated PSV + normal/low PI → May indicate compensatory increased cardiac output (e.g., in anemia).
Measuring technique for DV PSV:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava.
4. Angle correction is critical for PSV measurement: Align the Doppler beam as parallel as possible to the ductus venosus flow direction; maintain angle of insonation <15° for optimal accuracy; apply angle correction on the ultrasound machine for angles 0°–30°.
5. Measure during fetal rest (no breathing / movement); avoid fetal breathing movements which increase PSV variability.
6. Capture 3–4 uniform, representative waveforms during a stable period.
7. On each waveform, identify the highest point during the systolic phase (the peak of the first, largest envelope deflection).
8. Most modern ultrasound machines automatically measure PSV; record the mean PSV from 3–4 waveforms for reporting (express in cm/s).
9. Document the angle of insonation, angle correction applied, sample volume position, and technical quality for reproducibility.
10. Always measure PSV in context of concurrent end-diastolic velocity (EDV), PI, RI, and A-wave assessment for complete hemodynamic evaluation.
Normal PSV Reference Values for Ductus Venosus by Gestational Age
| GA (weeks) | DV PSV (cm/s) Mean ± SD | DV PSV Range (5th–95th centile) | DV PI Reference | Interpretation |
|---|---|---|---|---|
| 16 | 42 ± 6 | 32–52 | 0.66–0.88 | Early second trimester baseline |
| 18 | 45 ± 6 | 35–55 | 0.64–0.86 | Progressive increase in PSV |
| 20 | 48 ± 7 | 37–59 | 0.62–0.84 | Normal reference point |
| 22 | 51 ± 7 | 39–63 | 0.60–0.82 | Steady PSV increase |
| 24 | 54 ± 8 | 41–67 | 0.58–0.80 | Cardiac output rising |
| 26 | 57 ± 8 | 43–71 | 0.56–0.78 | Mid-gestation values |
| 28 | 60 ± 9 | 46–74 | 0.54–0.76 | Continued increase |
| 30 | 63 ± 9 | 48–78 | 0.52–0.74 | Progressive rise |
| 32 | 66 ± 10 | 50–82 | 0.50–0.72 | Late third trimester |
| 34 | 69 ± 10 | 52–86 | 0.48–0.70 | Approaching term |
| 36 | 72 ± 11 | 54–90 | 0.46–0.68 | Near-term values |
| 38 | 75 ± 11 | 56–94 | 0.44–0.66 | — |
| 40 | 78 ± 12 | 58–98 | 0.42–0.64 | Term reference values |
| 41–42 | 80 ± 12 | 60–100 | 0.40–0.62 | Post-term stable values |
Abnormal DV PSV patterns and clinical significance:
• PSV < 5th centile for GA (e.g., < 35 cm/s at 28 weeks) → Markedly reduced systolic flow velocity. If concurrent normal PI/RI, may indicate anemia, hypovolemia, or reduced cardiac output without resistance change. If concurrent elevated PI/RI, indicates severe hemodynamic compromise with reduced systolic function. Action: Assess hemoglobin/hematocrit; investigate cardiac function; serial monitoring.
• PSV progressively declining across serial scans → Worsening right ventricular systolic function or cardiac output deterioration. Action: Escalate surveillance; evaluate cardiac function; consider delivery if ≥32 weeks with other abnormalities.
• Severely reduced PSV (< 25 cm/s) + elevated PI + reversed A-wave → Critical triad indicating severe systolic dysfunction, hemodynamic failure, and imminent decompensation. Action: URGENT delivery if ≥32 weeks; immediate clinical assessment if <32 weeks.
• Elevated PSV (> 95th centile) + normal PI/RI → Increased flow velocity, may indicate compensatory increased cardiac output (e.g., anemia, polycythemia) without resistance elevation. Action: Assess fetal hemoglobin; investigate for anemia or other high-output states.
• Normal PSV + abnormal PI/RI + reversed A-wave → Resistance elevation and right heart dysfunction despite preserved systolic velocity; indicates venous or cardiac dysfunction without acute systolic failure. Action: Investigate cardiac function; urgent delivery consideration if ≥32 weeks.
Limitations of PSV as a standalone parameter:
PSV is angle-dependent, technique-dependent, and influenced by multiple non-hemodynamic factors (heart rate, cardiac contractility, blood volume, anemia, etc.). It provides limited independent prognostic value in IUGR and should never be used as a sole criterion for clinical decisions. PSV is most useful when:
• Combined with normalized indices (PI, RI) to provide complete hemodynamic assessment.
• Tracked serially to assess trend in cardiac output across time.
• Interpreted in context of A-wave status, diastolic flow, and other vessel Doppler.
• Used to investigate specific clinical questions (suspected anemia, cardiac dysfunction, high-output states).
Clinical Decision Framework (DV PSV in Context)
| DV PSV + Context | Concurrent PI/RI Status | A-Wave Status | Clinical Interpretation | Clinical Action |
|---|---|---|---|---|
| Normal PSV for GA | Normal PI/RI | Normal positive A-wave | Normal fetal hemodynamics | Routine surveillance |
| Normal PSV | Elevated PI/RI | Normal A-wave | Resistance elevation without systolic dysfunction; vascular/right heart dysfunction | Investigate cardiac function; serial monitoring; deliver if ≥34 weeks with growth restriction |
| Normal PSV | Elevated PI/RI | Reversed/absent A-wave | Venous hypertension + right atrial pressure elevation; right heart dysfunction | URGENT delivery ≥32 weeks; tertiary referral if <32 weeks; cardiac assessment |
| Reduced PSV (< 5th centile) | Normal PI/RI | Normal A-wave | Reduced flow velocity without resistance elevation; anemia, hypovolemia, or cardiac output reduction | Assess hemoglobin; investigate anemia; cardiac evaluation; serial monitoring |
| Reduced PSV | Elevated PI/RI | Normal A-wave | Combined resistance elevation + systolic dysfunction; moderate hemodynamic compromise | Daily CTG if ≥28 weeks; assess growth; deliver if ≥32 weeks with IUGR |
| Markedly reduced PSV (< 25 cm/s) | Elevated PI/RI | Reversed/absent A-wave | Severe systolic dysfunction + venous hypertension; critical hemodynamic failure | URGENT/EMERGENT delivery ≥32 weeks; urgent tertiary referral if <32 weeks; neonatal resuscitation standby |
| PSV declining trend across scans | Rising PI/RI | A-wave deteriorating | Progressive hemodynamic decompensation; worsening cardiac function and resistance | Accelerate surveillance to daily CTG; urgent delivery consideration; prepare for emergency intervention |
| Elevated PSV (> 95th centile) | Normal/low PI/RI | Normal A-wave | Increased cardiac output; possible anemia, polycythemia, or compensatory response | Assess hemoglobin; investigate for anemia or other high-output states; routine monitoring if anemia confirmed |
DV PSV Combined with Other Parameters:
For comprehensive fetal hemodynamic assessment, always integrate DV PSV with:
• Diastolic and mean velocities: Calculate PI and RI for normalized resistance assessment.
• A-wave assessment: Reversed/absent A-wave is a critical finding independent of PSV.
• Umbilical artery (UA) Doppler: Elevated UA PI/RI indicates placental insufficiency; combined with abnormal DV suggests IUGR with hemodynamic redistribution.
• Middle cerebral artery (MCA) Doppler: Reduced MCA PI indicates brain-sparing effect.
• Fetal growth parameters: Biometry (AC, EFW) confirms IUGR status.
• Fetal heart rate and heart rate variability: Bradycardia or reduced variability suggests fetal distress.
• Amniotic fluid volume: Oligohydramnios indicates more severe placental insufficiency.
Key points to remember:
• DV PSV is an absolute velocity measurement, not a resistance index; it reflects multiple factors (cardiac output, heart rate, blood volume, anemia, angle).
• PSV alone has limited prognostic value in IUGR; always interpret in context of normalized indices (PI, RI), A-wave status, and clinical parameters.
• PSV progressively increases with advancing gestation (42 cm/s at 16 weeks to 80 cm/s at 42 weeks) reflecting rising fetal cardiac output.
• Angle correction is essential for PSV accuracy; maintain insonation angle <15° or apply proper angle correction for angles up to 30°.
• Markedly reduced PSV + elevated PI/RI indicates severe systolic dysfunction and hemodynamic failure; urgent action warranted.
• Normal PSV + abnormal PI/RI indicates resistance/compliance abnormality without acute systolic dysfunction; still warrants investigation and monitoring.
• Elevated PSV + normal PI/RI + normal A-wave may indicate compensatory increased cardiac output (e.g., anemia); assess hemoglobin.
• Declining PSV trend across serial scans is more clinically significant than a single abnormal value; suggests progressive cardiac deterioration.
• PSV should always be measured on the proximal ductus venosus near entry into the IVC for standardization; mid or distal DV measurement yields different values.
• Fetal state matters: Measure during fetal quiescence; avoid measurement during breathing movements or hiccoughs which artificially alter PSV.
• Never use PSV alone for delivery decisions; integrate with PI/RI, A-wave, CTG, growth, and clinical context.
• Reversed A-wave is critical regardless of PSV—reversed A-wave with normal PSV still warrants urgent intervention if ≥32 weeks.
• DV PSV is most useful as part of comprehensive Doppler index assessment (UA + DV + MCA) for complete hemodynamic picture.
EDV (End-Diastolic Velocity) → EDV (End-Diastolic Velocity) in Ductus Venosus is the blood flow velocity recorded at the end of diastole (immediately before atrial contraction) in the ductus venosus waveform. It is an absolute velocity measurement expressed in cm/s, representing the lowest flow point during ventricular diastole and reflecting diastolic afterload and hepatic vascular resistance.
Definition and measurement:
DV EDV = The flow velocity at the end of the diastolic phase (just before the A-wave), measured in cm/s
What DV EDV measures:
EDV is a direct measure of diastolic flow velocity, which is predominantly determined by:
• Hepatic vascular resistance: EDV decreases as hepatic resistance rises (the primary driver in fetal IUGR). As placental insufficiency develops, hepatic vascular resistance increases, diastolic flow drops progressively.
• Right atrial pressure: Elevated right atrial pressure (from right heart dysfunction, tricuspid regurgitation, or venous congestion) reduces diastolic flow and can cause reversed diastolic flow.
• Venous compliance: Reduced compliance increases afterload and lowers diastolic velocity.
• Heart rate: Tachycardia shortens diastole and may artificially lower EDV measurements; bradycardia lengthens diastole.
• Angle of insonation: EDV is angle-dependent; measurements at angle >30° become unreliable.
• Fetal state: Breathing movements increase pulsatility and EDV variability; measurement during quiescence is essential.
Clinical significance of DV EDV:
EDV is clinically more significant than PSV in IUGR assessment because diastolic flow directly reflects vascular afterload and resistance:
• Reduced EDV (< 5th centile for GA) → Elevated hepatic vascular resistance; indicates placental insufficiency and IUGR.
• Absent EDV (near-zero diastolic flow) → Severe resistance elevation; critical hemodynamic deterioration; imminent decompensation.
• Reversed EDV (negative diastolic flow) → Flow reversal during diastole; critical right atrial pressure elevation; severe right heart dysfunction or tricuspid regurgitation; medical emergency.
• Progressive decline in EDV → Worsening resistance; high risk of acute decompensation.
• Absent or reversed EDV + reversed A-wave → Catastrophic hemodynamic failure; imminent fetal demise risk; URGENT delivery.
Measuring technique for DV EDV:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava.
4. Angle correction is critical for EDV measurement: Align the Doppler beam as parallel as possible to the ductus venosus flow direction; maintain angle of insonation <15° for optimal accuracy; apply angle correction on the ultrasound machine for angles 0°–30°.
5. Measure during fetal rest (no breathing / movement); avoid fetal breathing movements which distort EDV and increase pulsatility.
6. Capture 3–4 uniform, representative waveforms during a stable, quiescent period.
7. On each waveform, identify the lowest point during the diastolic phase, just before the A-wave (atrial contraction) begins. This is typically the trough of the waveform between the main systolic peak and the smaller A-wave peak.
8. Most modern ultrasound machines automatically measure EDV; record the mean EDV from 3–4 waveforms for reporting (express in cm/s).
9. Note the presence and direction of diastolic flow: Positive EDV indicates antegrade (toward heart) flow; absent EDV indicates near-zero diastolic flow; negative EDV indicates reversed (retrograde) diastolic flow.
10. Always measure EDV in context of concurrent PSV, PI, RI, and A-wave assessment for complete hemodynamic evaluation.
11. Document angle of insonation, angle correction applied, diastolic flow direction, sample volume position, and technical quality for reproducibility.
Normal EDV Reference Values for Ductus Venosus by Gestational Age
| GA (weeks) | DV EDV (cm/s) Mean ± SD | DV EDV Range (5th–95th centile) | S/D Ratio Reference | Interpretation |
|---|---|---|---|---|
| 16 | 15 ± 3 | 10–22 | 3.2–3.8 | Early second trimester; low diastolic flow |
| 18 | 16 ± 3 | 11–23 | 3.1–3.7 | Progressive EDV increase |
| 20 | 18 ± 4 | 12–26 | 3.0–3.6 | Normal reference point |
| 22 | 20 ± 4 | 14–28 | 2.95–3.5 | Diastolic flow rising |
| 24 | 22 ± 4 | 16–30 | 2.9–3.4 | Steady EDV increase |
| 26 | 24 ± 5 | 17–32 | 2.85–3.3 | Mid-gestation values |
| 28 | 26 ± 5 | 19–34 | 2.8–3.2 | Continued rise |
| 30 | 28 ± 5 | 21–36 | 2.75–3.1 | Progressive increase |
| 32 | 30 ± 6 | 23–38 | 2.7–3.0 | Late third trimester |
| 34 | 32 ± 6 | 25–40 | 2.6–2.95 | Approaching term |
| 36 | 34 ± 6 | 27–42 | 2.5–2.9 | Near-term values |
| 38 | 36 ± 7 | 28–44 | 2.45–2.85 | — |
| 40 | 38 ± 7 | 30–46 | 2.4–2.8 | Term reference values |
| 41–42 | 40 ± 7 | 32–48 | 2.35–2.75 | Post-term stable values |
Abnormal DV EDV patterns and clinical significance:
• EDV < 5th centile for GA (e.g., < 10 cm/s at 28 weeks) → Markedly reduced diastolic flow velocity. Indicates elevated hepatic vascular resistance from placental insufficiency, IUGR, or right heart dysfunction. Action: Confirm IUGR with biometry; assess UA and MCA Doppler; serial monitoring every 3–7 days; consider delivery if ≥34 weeks with growth restriction.
• EDV approaching zero (near-absent diastolic flow) → Severely elevated hepatic vascular resistance; critical hemodynamic deterioration. Action: Daily CTG if ≥28 weeks; assess PI/RI for complete picture; urgent delivery consideration if ≥32 weeks.
• Absent EDV (zero diastolic flow) → No flow during diastole; critical resistance elevation; precursor to reversed diastolic flow. Action: URGENT evaluation; escalate to twice-daily CTG; deliver if ≥32 weeks; tertiary referral if <32 weeks.
• Reversed EDV (negative diastolic flow) → Retrograde flow during diastole; reversed velocity toward the umbilical vein; indicates severe right atrial pressure elevation exceeding ductus venosus pressure. Sign of severe right heart dysfunction, tricuspid regurgitation, or hepatic congestion. Action: MEDICAL EMERGENCY; URGENT/EMERGENT delivery if ≥32 weeks; dual obstetric-neonatal team mobilization; neonatal resuscitation standby.
• EDV progressively declining across serial scans → Worsening hepatic resistance and deteriorating fetal hemodynamics; high risk of acute decompensation. Action: Accelerate surveillance to daily CTG; urgent delivery consideration; prepare for emergency intervention.
• Absent or reversed EDV + reversed A-wave → Severe combined diastolic and atrial flow reversal; catastrophic hemodynamic failure. Action: IMMEDIATE EMERGENCY DELIVERY if ≥30 weeks; critical assessment if <30 weeks; prepare for resuscitation.
• Normal EDV + elevated PI/RI → Preserved diastolic velocity despite elevated resistance indices; may indicate compensatory mechanism or measurement variability. Action: Confirm measurements; serial monitoring; investigate for other causes.
Relationship between EDV, diastolic flow direction, and hemodynamic status:
The ductus venosus waveform reveals progressive hemodynamic derangement in stages:
• Stage 1 (Mild compromise): EDV reduced but positive; PI/RI elevated; A-wave normal.
• Stage 2 (Moderate compromise): EDV severely reduced (near-zero); PI/RI markedly elevated; A-wave diminished.
• Stage 3 (Severe/Critical compromise): Absent EDV (zero diastolic flow); reversed EDV (negative diastolic flow); A-wave normal or mildly reversed.
• Stage 4 (Catastrophic failure): Reversed EDV + reversed A-wave; complete flow reversal during diastole and atrial contraction; imminent fetal demise.
In severe IUGR with right heart dysfunction, the sequence often follows: reduced EDV → absent EDV → reversed EDV → reversed A-wave. Each stage represents progressive hemodynamic failure and warrants escalated clinical response.
Clinical Decision Thresholds (DV EDV Status)
| DV EDV Status | Hepatic Vascular Resistance | Fetal Hemodynamic Status | Clinical Interpretation | Clinical Action |
|---|---|---|---|---|
| Positive EDV within normal range for GA | Normal | Compensated; normal | Normal diastolic flow; adequate hepatic perfusion | Routine antenatal care; standard surveillance intervals |
| Positive EDV reduced (< 5th centile) but detectable | Elevated | Early compensation | Reduced diastolic flow; mild to moderate resistance elevation; IUGR suspected | Confirm IUGR with biometry; assess UA/MCA Doppler; serial DV every 3–7 days; CTG if ≥28 weeks |
| EDV severely reduced, approaching zero | Severely elevated | Advanced decompensation | Near-absent diastolic flow; severe resistance elevation; advanced hemodynamic compromise | Daily CTG if ≥28 weeks; assess growth parameters and other Doppler; consider delivery if ≥32 weeks with IUGR |
| Absent EDV (zero diastolic flow) | Critical resistance | Imminent decompensation | No flow during diastole; critical hemodynamic failure; precursor to flow reversal | URGENT twice-daily CTG; hospitalize if ≥28 weeks; deliver if ≥32 weeks; urgent tertiary referral if <32 weeks; prepare for neonatal intervention |
| Reversed EDV (negative diastolic flow) | Reverse pressure gradient | Critical failure | Retrograde diastolic flow; right atrial pressure exceeds DV pressure; severe right heart dysfunction | URGENT/EMERGENT delivery ≥30 weeks; dual obstetric-neonatal team; prepare resuscitation; if <30 weeks, intensive counselling on viability; very high mortality risk |
| Reversed EDV + reversed A-wave | Complete hemodynamic reversal | Catastrophic failure | Flow reversal during both diastole and atrial systole; complete hemodynamic derangement | IMMEDIATE EMERGENCY DELIVERY if ≥28 weeks; if <28 weeks, critical counselling on outcome; prepare for resuscitation; perinatal mortality very high |
| EDV progressively declining (trend) | Progressively worsening | Acute decompensation risk | Serial EDV decline indicates worsening resistance and hemodynamic deterioration | Escalate surveillance to daily CTG; assess fetal movement; urgent delivery consideration ≥30 weeks; emergency assessment if trend continues rapidly |
DV EDV vs. DV PSV in IUGR Assessment:
• EDV is clinically superior to PSV in detecting and monitoring hemodynamic compromise because:
– EDV directly reflects afterload and vascular resistance (the primary pathology in IUGR).
– PSV may remain relatively preserved even in advanced IUGR; EDV deteriorates progressively.
– Absent or reversed EDV is always pathologic; absent/reversed PSV is rare.
– EDV trend is more sensitive to progressive hemodynamic deterioration.
• Combined PSV + EDV assessment provides complete picture:
– Normal PSV + reduced EDV = resistance elevation without systolic dysfunction (compensated).
– Reduced PSV + reduced/absent EDV = combined systolic and diastolic dysfunction (decompensated).
– Normal PSV + absent EDV = severe diastolic dysfunction with preserved systole (severe resistance).
– Reversed PSV + reversed EDV = catastrophic bidirectional flow reversal (imminent demise).
Key points to remember:
• DV EDV is an absolute velocity measurement primarily reflecting hepatic vascular resistance (the key pathology in IUGR).
• EDV is clinically more significant than PSV in IUGR assessment; EDV deterioration indicates worsening hemodynamic compromise.
• EDV progressively increases with advancing gestation (15 cm/s at 16 weeks to 40 cm/s at 42 weeks) reflecting falling hepatic resistance with fetal maturation.
• Reduced or absent EDV indicates elevated hepatic vascular resistance—the hallmark of IUGR with hemodynamic redistribution.
• Reversed EDV is a critical, time-sensitive finding indicating right atrial pressure elevation and right heart dysfunction; warrants URGENT delivery if ≥30 weeks.
• Absent + reversed EDV combination is catastrophic; indicates complete hemodynamic failure and imminent fetal demise risk.
• Angle correction is essential for EDV accuracy; maintain insonation angle <15° for optimal accuracy.
• Progressive EDV decline across serial scans is more clinically significant than a single reduced value; indicates worsening hemodynamic status.
• EDV deterioration occurs predictably before A-wave reversal; abnormal EDV warrants escalated surveillance even if A-wave still appears normal.
• Measure EDV on the proximal ductus venosus near IVC entry for standardization; mid or distal DV measurement yields different values.
• Fetal state matters: Measure during fetal quiescence; breathing movements and hiccoughs alter EDV and increase measurement variability.
• Absent or reversed EDV always warrants urgent clinical assessment; never defer decision-making with these findings.
• EDV provides earlier warning of hemodynamic decompensation than A-wave reversal; EDV abnormality should trigger escalated monitoring.
• Combine EDV assessment with PI/RI, A-wave, PSV, UA Doppler, and MCA Doppler for comprehensive hemodynamic picture.
• Never use EDV alone for delivery decisions; but absent or reversed EDV is a critical component of comprehensive assessment mandating urgent action.
MV (Mean Velocity) → Mean Velocity (MV) in Ductus Venosus is the average blood flow velocity calculated from the entire velocity envelope (from the beginning of systole through diastole and atrial contraction) in the ductus venosus waveform. It is an absolute velocity measurement expressed in cm/s, representing the mathematical average flow speed across the complete cardiac cycle and reflecting overall perfusion and cardiac output contribution.
Definition and calculation:
DV MV = Integrated area under the velocity-time envelope ÷ Duration of one cardiac cycle
(Automatically calculated by most modern ultrasound machines)
Relationship to other Doppler parameters:
Mean velocity is the mathematical denominator for calculating normalized resistance indices:
• Pulsatility Index (PI) = (S − D) ÷ MV — MV in denominator normalizes the S−D difference by mean flow.
• Resistance Index (RI) = (S − D) ÷ S — RI does not depend on MV.
• S/D Ratio = S ÷ D — S/D does not depend on MV.
This means MV is critical for PI calculation; changes in MV directly affect PI values even if S and D remain constant.
What DV MV measures:
Mean velocity reflects several hemodynamic factors:
• Cardiac output: MV increases with higher cardiac output (e.g., anemia, tachycardia, compensatory states).
• Vascular resistance and compliance: MV decreases when resistance rises or compliance falls (e.g., in IUGR, right heart dysfunction).
• Flow pulsatility: More pulsatile waveforms (high PI) generally have lower MV relative to PSV; flatter, less pulsatile waveforms have higher MV.
• Heart rate: Tachycardia may alter MV calculation; bradycardia lengthens the time integral.
• Fetal state and breathing: Breathing movements increase pulsatility and alter MV.
• Measurement angle: MV is angle-dependent; angle correction should be applied.
Clinical significance of DV MV:
Mean velocity alone has limited independent prognostic value in IUGR because it is influenced by multiple factors unrelated to resistance (heart rate, cardiac output, anemia, technique). However, MV becomes clinically significant in specific contexts:
• Reduced MV + elevated PI → Indicates both reduced flow perfusion AND elevated pulsatility; severe hemodynamic compromise.
• Reduced MV + normal PI → Reduced perfusion without pulsatility change; suggests reduced cardiac output or increased anemia without resistance elevation.
• Progressive MV decline across serial scans → Indicates worsening cardiac perfusion or output deterioration.
• Very low MV (< 10 cm/s) + reversed A-wave → Critical hemodynamic failure with severely reduced diastolic perfusion.
• MV trend combined with EDV trend → Both declining indicates progressive hemodynamic decompensation with reduced diastolic perfusion.
Measuring technique for DV MV:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava, avoiding the junction.
4. Angle correction is important for MV measurement: Align the Doppler beam as parallel as possible to the ductus venosus flow direction; maintain angle of insonation <15° for optimal accuracy; apply angle correction on the ultrasound machine for angles 0°–30°.
5. Measure during fetal rest (no breathing / movement); breathing movements distort the waveform and alter MV calculations.
6. Capture 3–4 uniform, representative waveforms during a stable, quiescent period. Avoid measuring during fetal hiccoughs or accelerations.
7. The ultrasound machine automatically traces the entire velocity envelope (the outer border of the Doppler signal from start of systole through completion of the cardiac cycle) and calculates mean velocity by integrating the area under the curve and dividing by cardiac cycle time.
8. Do not manually measure MV; rely on the machine's automated envelope tracing and calculation for accuracy.
9. Record the mean MV from 3–4 representative waveforms for reporting (express in cm/s).
10. Always measure MV in context of concurrent PSV, EDV, PI, RI, and A-wave assessment for complete hemodynamic evaluation.
11. Document angle of insonation, angle correction applied, sample volume position, technical quality, and fetal state for reproducibility.
Normal Mean Velocity Reference Values for Ductus Venosus by Gestational Age
| GA (weeks) | DV MV (cm/s) Mean ± SD | DV MV Range (5th–95th centile) | DV PI Reference | Interpretation |
|---|---|---|---|---|
| 16 | 14 ± 2.5 | 10–19 | 0.66–0.88 | Early second trimester baseline |
| 18 | 15 ± 2.8 | 11–20 | 0.64–0.86 | Progressive MV increase |
| 20 | 17 ± 3 | 12–22 | 0.62–0.84 | Normal reference point |
| 22 | 19 ± 3.2 | 14–25 | 0.60–0.82 | Steady MV increase |
| 24 | 21 ± 3.5 | 16–27 | 0.58–0.80 | Mid-gestation values |
| 26 | 23 ± 3.8 | 18–29 | 0.56–0.78 | Continued rise |
| 28 | 25 ± 4 | 19–31 | 0.54–0.76 | Progressive increase |
| 30 | 27 ± 4.2 | 21–34 | 0.52–0.74 | Progressive rise |
| 32 | 29 ± 4.5 | 23–36 | 0.50–0.72 | Late third trimester |
| 34 | 31 ± 4.8 | 25–38 | 0.48–0.70 | Approaching term |
| 36 | 33 ± 5 | 27–40 | 0.46–0.68 | Near-term values |
| 38 | 35 ± 5.2 | 29–42 | 0.44–0.66 | — |
| 40 | 37 ± 5.5 | 31–44 | 0.42–0.64 | Term reference values |
| 41–42 | 39 ± 5.8 | 32–46 | 0.40–0.62 | Post-term stable values |
Abnormal DV MV patterns and clinical significance:
• MV < 5th centile for GA (e.g., < 15 cm/s at 28 weeks) → Markedly reduced mean flow velocity. If concurrent normal or low PI, may indicate reduced cardiac output or anemia. If concurrent elevated PI, indicates both reduced perfusion AND elevated pulsatility; severe hemodynamic stress. Action: Assess hemoglobin; investigate cardiac function; serial monitoring every 3–7 days; CTG if ≥28 weeks.
• MV progressively declining across serial scans → Worsening cardiac perfusion or output deterioration. Action: Escalate surveillance; evaluate cardiac function; consider delivery if ≥32 weeks with concurrent abnormalities.
• Very low MV (< 10 cm/s) + elevated PI + reversed A-wave → Critical triad indicating severe perfusion failure, hemodynamic derangement, and imminent decompensation. Action: URGENT delivery if ≥32 weeks; immediate clinical assessment if <32 weeks.
• Low MV + low PI (both reduced) → Reduced perfusion with decreased pulsatility; unusual pattern suggesting reduced cardiac output without resistance elevation (possible anemia, hypovolemia, or cardiac dysfunction). Action: Assess hemoglobin and cardiac function; serial monitoring.
• Normal MV + elevated PI → Normal perfusion but elevated pulsatility; resistance elevation without acute perfusion failure. Action: Standard monitoring; deliver if ≥34 weeks with IUGR.
• Elevated MV + normal/low PI → Increased flow perfusion; may indicate compensatory high-output state (anemia, polycythemia). Action: Assess hemoglobin; routine monitoring if anemia confirmed.
MV's role in Pulsatility Index (PI) calculation:
Understanding the relationship between MV, S, D, and PI is critical:
• PI = (S − D) ÷ MV — If MV decreases while S and D remain constant, PI will increase (more pulsatile).
• PI = (S − D) ÷ MV — If MV increases while S and D remain constant, PI will decrease (less pulsatile).
• A waveform can have elevated PI for two reasons: (1) Large S−D difference (increased pulsatility from resistance elevation), or (2) Low MV (reduced overall perfusion).
• In severe IUGR, both mechanisms operate: S−D increases (resistance ↑) AND MV decreases (perfusion ↓), resulting in markedly elevated PI.
• Monitoring both MV and PI separately provides more complete hemodynamic information than PI alone.
Clinical Decision Framework (DV MV in Context)
| DV MV Status | Concurrent PI Status | A-Wave Status | Clinical Interpretation | Clinical Action |
|---|---|---|---|---|
| Normal MV for GA | Normal PI | Normal A-wave | Normal perfusion and resistance | Routine surveillance |
| Normal MV | Elevated PI | Normal A-wave | Preserved perfusion; elevated pulsatility from resistance increase | Confirm IUGR; assess growth; serial monitoring; deliver if ≥34 weeks with growth restriction |
| Normal MV | Elevated PI | Reversed/absent A-wave | Preserved flow speed but abnormal resistance; right heart dysfunction | URGENT delivery ≥32 weeks; cardiac assessment; tertiary referral if <32 weeks |
| Reduced MV (< 5th centile) | Normal/low PI | Normal A-wave | Reduced perfusion without resistance elevation; anemia, cardiac output reduction, or technique issue | Assess hemoglobin; investigate cardiac function; confirm angle/technique; serial monitoring |
| Reduced MV | Elevated PI | Normal A-wave | Reduced perfusion PLUS elevated resistance; moderate hemodynamic compromise | Daily CTG if ≥28 weeks; assess biometry; serial Doppler; deliver if ≥32 weeks with IUGR |
| Markedly reduced MV (< 10 cm/s) | Markedly elevated PI | Reversed/absent A-wave | Severe perfusion failure + resistance elevation + venous hypertension; critical compromise | URGENT/EMERGENT delivery ≥30 weeks; dual team mobilization; prepare resuscitation; critical counselling if <30 weeks |
| MV declining trend | PI rising trend | A-wave deteriorating | Progressive perfusion decline; progressive hemodynamic decompensation | Accelerate to daily CTG; urgent delivery consideration; prepare for emergency intervention |
| Elevated MV | Normal/low PI | Normal A-wave | Increased cardiac output; compensatory high-output state (possible anemia) | Assess hemoglobin; if anemia confirmed, routine monitoring; manage anemia if indicated |
MV in the context of PSV and EDV:
Complete hemodynamic assessment requires understanding all three velocity parameters:
• PSV high, EDV low, MV low: Highly pulsatile waveform; elevated resistance with reduced overall perfusion; severe IUGR pattern.
• PSV normal, EDV low, MV low: Diastolic-predominant resistance elevation; reduced diastolic perfusion; moderate IUGR pattern.
• PSV normal, EDV normal, MV normal: Normal triphasic waveform; no hemodynamic compromise; reassuring.
• PSV low, EDV low, MV very low: Globally reduced flow velocity; severe systolic and diastolic dysfunction; critical cardiac compromise.
• PSV high, EDV normal, MV normal: Exaggerated systolic peak; possible compensatory response; monitor for progression.
Key points to remember:
• DV Mean Velocity is an absolute velocity measurement reflecting perfusion and cardiac output contribution.
• MV alone has limited independent prognostic value; always interpret in context of PI/RI, PSV, EDV, and A-wave.
• MV is the mathematical foundation for PI calculation: PI = (S − D) ÷ MV; changes in MV directly affect PI values.
• MV progressively increases with advancing gestation (14 cm/s at 16 weeks to 39 cm/s at 42 weeks) reflecting rising fetal cardiac output.
• Reduced MV + elevated PI indicates severe hemodynamic compromise with both perfusion failure AND resistance elevation.
• Normal MV + elevated PI indicates preserved perfusion despite resistance elevation; less acutely concerning but still abnormal.
• Reduced MV + normal PI is uncommon and suggests reduced cardiac output without resistance change; investigate for cardiac dysfunction or anemia.
• Angle correction is important for MV accuracy; maintain insonation angle <15° for optimal accuracy.
• Progressive MV decline across serial scans is more clinically significant than a single reduced value; indicates worsening perfusion.
• Very low MV (< 10 cm/s) + reversed A-wave indicates critical hemodynamic failure; urgent action warranted.
• Fetal state matters: Measure during fetal quiescence; breathing movements distort the velocity envelope and alter MV calculations.
• Do not manually measure MV; always use machine-calculated values from automated envelope tracing.
• Elevated MV + normal PI + normal A-wave suggests high-output compensatory state; assess for anemia.
• Combine MV with PSV and EDV assessment to determine waveform shape and resistance pattern.
• Serial MV monitoring is valuable for detecting progressive deterioration; trend is more important than absolute value.
• MV provides additional hemodynamic context beyond PI/RI; separate reporting of MV enhances clinical assessment.
• MV should never be used as a sole criterion for clinical decisions; integrate with all available Doppler parameters and clinical context.
A-wave (Atrial Velocity) → A-wave (Atrial Velocity) in Ductus Venosus is the peak blood flow velocity occurring during right atrial contraction (atrial systole), represented as the third, smaller peak in the triphasic DV waveform that appears after the diastolic trough. It reflects right atrial contractility, right atrial afterload, and atrial-ventricular hemodynamic compatibility.
Definition and physiologic basis:
DV A-wave = Peak velocity during atrial contraction (expressed in cm/s or as a waveform characteristic)
The ductus venosus waveform consists of three velocity peaks across one cardiac cycle:
1. S-peak (Systolic): Blood flow surge during ventricular systole (right ventricle contracting); this is the largest peak.
2. D-trough (Diastolic): Blood flow decelerates during ventricular diastole (ventricle relaxing); this is the lowest point before atrial contraction begins.
3. A-peak (Atrial): Blood flow accelerates again during atrial contraction (right atrium contracting); this is the third smaller peak that occurs after diastole.
Under normal conditions, the A-wave is always positive (antegrade flow), indicating the atrium is effectively pushing blood forward toward the heart.
What DV A-wave measures:
The A-wave reflects several important hemodynamic factors:
• Right atrial contractility: A strong, prominent A-wave indicates robust atrial contraction; diminished A-wave suggests reduced atrial function.
• Right atrial afterload: A-wave velocity depends on the pressure gradient between the right atrium and the ductus venosus. Elevated right atrial pressure reduces A-wave velocity.
• Right ventricular diastolic function: Impaired RV diastolic compliance (stiffness) reduces the right atrium's ability to fill the ventricle and increases right atrial pressure, diminishing the A-wave.
• Tricuspid valve function: A-wave abnormalities may indicate tricuspid regurgitation, which elevates right atrial pressure.
• Atrial-ventricular pressure gradient: When right atrial pressure exceeds ductus venosus pressure, flow reverses, and the A-wave becomes negative (reversed A-wave).
• Fetal heart rate variability: Irregular heart rhythms (arrhythmias) can alter A-wave morphology; occasional dropped A-waves are normal.
Clinical significance of A-wave abnormalities:
The A-wave is the single most important DV Doppler marker of fetal hemodynamic compromise.
• Normal positive A-wave: Reassuring; indicates adequate right heart function.
• Diminished A-wave (reduced amplitude): Suggests mild right heart dysfunction or elevated right atrial pressure; warrants monitoring.
• Absent or barely visible A-wave: Indicates significant right atrial pressure elevation or severely reduced atrial contractility; concerning finding requiring urgent evaluation.
• Reversed A-wave (negative A-wave): CRITICAL FINDING. Indicates right atrial pressure exceeds ductus venosus pressure; severe right heart dysfunction or tricuspid regurgitation; blood flows backward during atrial contraction. Associated with high risk of imminent fetal decompensation, intrauterine fetal death, and perinatal death. Reversed A-wave alone justifies urgent delivery consideration if ≥32 weeks, even if other parameters are borderline.
• Oscillating or bizarre A-wave pattern: May indicate cardiac arrhythmia or severe hemodynamic instability.
Measuring technique for DV A-wave:
1. Obtain a sagittal section of the fetal abdomen; identify the ductus venosus as a thin vessel connecting the umbilical vein (left) to the inferior vena cava (right).
2. Use color Doppler to confirm flow direction (toward the heart); switch to PW Doppler.
3. Place PW Doppler sample volume (2–3 mm) in the proximal ductus venosus, ideally near the entry into the inferior vena cava.
4. Angle correction: Maintain angle of insonation <15° for optimal accuracy; apply angle correction if needed.
5. Measure during fetal rest (no breathing / movement); breathing movements distort the waveform and make A-wave assessment difficult.
6. Capture at least 4–5 cardiac cycles to ensure proper A-wave characterization; single cycles may miss A-wave abnormalities.
7. On the waveform display, identify the three-peak triphasic pattern:
– First large peak = S-peak (systole)
– Trough between peaks = D-trough (diastole)
– Second smaller peak after trough = A-peak (atrial contraction)
8. Assess A-wave direction and amplitude:
– Positive (upward) A-wave = Normal antegrade flow during atrial contraction
– Diminished A-wave = Reduced amplitude, barely visible above baseline
– Absent A-wave = No visible third peak; waveform appears biphasic (only S and D)
– Reversed A-wave = Downward (negative) deflection below baseline; flow reversal during atrial contraction
9. Most machines do not automatically measure A-wave velocity; A-wave is qualitatively assessed based on waveform appearance and direction. Some advanced systems display A-wave velocity in cm/s; if available, record it.
10. Classify A-wave status for reporting: Normal positive, Diminished, Absent, or Reversed.
11. Always assess A-wave in context of concurrent S, D, PI, RI, and clinical parameters for complete evaluation.
12. Document A-wave morphology, direction, regularity, sample volume position, fetal heart rate, and fetal state for reproducibility.
A-wave Classification and Reference Patterns for Ductus Venosus
| A-wave Classification | Waveform Appearance | Flow Direction | Clinical Significance | GA-Based Interpretation |
|---|---|---|---|---|
| Normal Positive A-wave | Triphasic waveform with distinct third peak; upward deflection above baseline | Antegrade (toward heart) | Normal right heart function; adequate atrial contractility | At any GA, normal A-wave is reassuring; continue routine surveillance |
| Diminished A-wave | Third peak reduced in amplitude; barely visible but still above baseline | Antegrade but weak | Mild right heart dysfunction; elevated right atrial pressure (early stage) | Warrants serial monitoring every 3–7 days; investigate if concurrent PI/RI abnormal |
| Absent A-wave | Biphasic waveform; only S and D peaks visible; no third peak or barely perceptible third peak | No flow or minimal antegrade | Significant right atrial pressure elevation or severely reduced atrial contractility; advanced hemodynamic compromise | URGENT evaluation; daily CTG if ≥28 weeks; deliver if ≥32 weeks; urgent referral if <32 weeks |
| Reversed A-wave | Triphasic waveform but third peak deflects DOWNWARD below baseline; below-zero velocity | Retrograde (backward, away from heart) | CRITICAL FINDING. Right atrial pressure exceeds DV pressure; severe right heart dysfunction or tricuspid regurgitation; imminent hemodynamic failure | At ≥32 weeks: URGENT delivery within 24–48 hours. At 28–31 weeks: urgent tertiary referral, daily CTG, hospitalize. At <28 weeks: critical counselling on outcome and viability. High perinatal mortality risk. |
| Oscillating/Bizarre A-wave | A-wave waveform is irregular, variable, or shows multiple small oscillations | Variable direction | Cardiac arrhythmia or severe hemodynamic instability; may indicate irregular atrial contractions | Obtain fetal ECG if available; escalate surveillance; investigate for cardiac anomaly |
Progressive stages of A-wave abnormality in IUGR:
The ductus venosus waveform typically deteriorates in a predictable sequence as fetal hemodynamic compromise worsens:
• Stage 1 (Mild compromise): S/D ratio elevated; PI/RI elevated; A-wave normal and positive.
• Stage 2 (Moderate compromise): S/D ratio further elevated; PI/RI markedly elevated; A-wave diminished in amplitude.
• Stage 3 (Severe compromise): Diastolic flow severely reduced or absent; PI/RI very high; A-wave barely visible or absent.
• Stage 4 (Critical/Catastrophic compromise): Reversed diastolic flow (reversed EDV); reversed A-wave; complete hemodynamic failure; imminent fetal demise risk.
Progression through these stages is not always linear; rapid deterioration can occur, particularly when reversed A-wave develops.
Clinical significance of reversed A-wave:
Reversed A-wave is one of the most ominous findings in fetal Doppler assessment. Multiple large prospective studies have demonstrated:
• Reversed A-wave has 70–100% sensitivity and 90–95% specificity for predicting adverse perinatal outcome in IUGR fetuses.
• Reversed A-wave is associated with an 8–10 fold increased risk of perinatal death compared to normal Doppler.
• Mean survival from reversed A-wave detection is approximately 2–7 days if expectant management continued in advanced IUGR.
• Delivery within 24–48 hours of reversed A-wave diagnosis significantly improves neonatal survival and reduces serious morbidity compared to delayed delivery.
• Reversed A-wave predicts outcome better than any other single Doppler parameter, including absent diastolic flow in umbilical artery.
Clinical Decision Thresholds (DV A-wave Status)
| A-wave Status | Right Heart Function | Fetal Hemodynamic Status | Clinical Interpretation | Clinical Action by Gestational Age |
|---|---|---|---|---|
| Normal positive A-wave | Normal | Compensated; normal | Reassuring; normal right atrial function | Any GA: Routine surveillance (3–4 week intervals); normal obstetric management |
| Diminished A-wave | Mildly impaired | Early hemodynamic stress | Subtle right heart dysfunction; elevated right atrial pressure (early stage) | Any GA: Serial Doppler every 3–7 days; CTG if ≥28 weeks; if concurrent PI/RI abnormal, accelerate surveillance; consider delivery ≥34 weeks with growth restriction |
| Absent A-wave | Significantly impaired | Advanced hemodynamic failure | Severe right atrial pressure elevation or severely reduced contractility; critical finding | ≥34 weeks: Deliver within 24–48 hours. 30–33 weeks: Urgent tertiary referral; daily CTG; hospitalize; consider delivery after steroid prophylaxis. 28–29 weeks: Urgent referral; intensive surveillance; counsel on risks/benefits of delivery vs. expectant management. <28 weeks: Critical counselling; viability discussion. |
| Reversed A-wave | Severely impaired/failing | Critical decompensation | CRITICAL FINDING. Right atrial pressure exceeds DV pressure; retrograde flow; severe right heart dysfunction; imminent decompensation risk | ≥32 weeks: URGENT DELIVERY within 24 hours. 30–31 weeks: URGENT delivery after steroid prophylaxis (if time permits); intensive monitoring if delivery deferred. 28–29 weeks: Urgent tertiary referral; intensive counselling on outcome; dual obstetric-neonatal team assessment; if delivery chosen, steroid prophylaxis and delivery planning. <28 weeks: Intensive counselling; viability discussion; perinatology/neonatology consultation. All cases: Mobilize obstetric and neonatal teams; prepare for emergency delivery and neonatal resuscitation. |
| A-wave rapidly changing (acute deterioration) | Rapidly failing | Acute hemodynamic crisis | Acute onset or rapid progression of A-wave abnormality; suggests imminent decompensation | ≥30 weeks: Emergency delivery consideration. <30 weeks: Urgent evaluation; if confirmed acute change, emergency delivery discussion. Do NOT delay for repeat imaging if clinical deterioration suspected. |
A-wave in integrated Doppler assessment:
The A-wave must always be interpreted as part of complete hemodynamic evaluation:
• Normal S/D/PI + Normal A-wave = Reassuring; no hemodynamic compromise.
• Elevated S/D/PI + Normal A-wave = Resistance elevation without acute right heart dysfunction (early IUGR).
• Elevated S/D/PI + Diminished A-wave = Progressive hemodynamic compromise; right heart dysfunction developing.
• Elevated S/D/PI + Absent A-wave = Advanced hemodynamic failure; urgent intervention needed.
• Elevated S/D/PI + Reversed A-wave = Critical hemodynamic failure; URGENT delivery if ≥32 weeks.
• Normal S/D/PI + Reversed A-wave = Unusual; indicates isolated right heart dysfunction or tricuspid pathology; warrants cardiac assessment.
• Absent EDV + Reversed A-wave = Catastrophic hemodynamic failure; dual flow reversal (diastole + atrial contraction); highest risk.
Key points to remember:
• A-wave is the most clinically significant DV Doppler parameter and the single best marker of fetal hemodynamic compromise.
• Normal positive A-wave is reassuring; indicates adequate right heart function regardless of other Doppler abnormalities.
• Diminished A-wave indicates early right heart dysfunction; warrants escalated surveillance every 3–7 days.
• Absent A-wave is concerning; indicates significant hemodynamic failure; demands urgent clinical assessment and consideration of delivery if ≥32 weeks.
• REVERSED A-wave is a CRITICAL, TIME-URGENT finding that represents imminent fetal decompensation and high perinatal mortality risk.
• Reversed A-wave alone justifies urgent delivery consideration at ≥32 weeks, even if other parameters are borderline. Do not delay delivery for confirmatory testing.
• Reversed A-wave has 70–100% sensitivity and 90–95% specificity for adverse outcome in IUGR; associated with 8–10 fold increased mortality risk.
• Mean survival time after reversed A-wave detection is 2–7 days; delivery within 24–48 hours significantly improves survival.
• A-wave abnormalities may precede other signs of fetal distress (abnormal CTG, biometric growth restriction, oligohydramnios); A-wave is early warning signal.
• Always assess A-wave in context of concurrent S, D, PI, RI, EDV, and clinical parameters for complete hemodynamic picture.
• A-wave abnormality combined with reversed EDV or absent EDV is catastrophic; indicates dual flow reversal and imminent demise.
• Measure A-wave during fetal rest/quiescence; breathing movements and arrhythmias distort waveform assessment.
• Obtain at least 4–5 cardiac cycles for proper A-wave characterization; single cycles may miss abnormalities.
• A-wave should be qualitatively classified (normal/diminished/absent/reversed); most machines do not provide automated A-wave velocity measurements.
• Progressive A-wave deterioration across serial scans indicates accelerating hemodynamic decompensation; warrants urgent action.
• Reversed A-wave is independent of delivery mode; both vaginal and cesarean delivery are acceptable if urgent delivery indicated.
• Communication with neonatal team is essential when reversed A-wave diagnosed; prepare for potential intensive neonatal care needs.
• Never attribute reversed A-wave to arrhythmia or technical error without careful assessment; when in doubt, repeat scan promptly and consider urgent delivery planning.
No comments:
Post a Comment